Formation mechanism of IVT reaction byproducts and design and application of inhibitory modules

By introducing a repression module in the in vitro transcription reaction, the hairpin structure is used to repress the formation of dsRNA and 3' end extension byproducts, the problem of byproducts affecting mRNA purity and immunogenicity in in vitro transcription reactions is solved, and efficient mRNA is achieved preparation.

CN118109460BActive Publication Date: 2024-11-19KACTUS BIOSYSTEMS SHANGHAI LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310723035.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2022-12-28
Filing Date
2023-06-16
Publication Date
2024-11-19
Estimated Expiration
2043-06-16

AI Technical Summary

Technical Problem

The formation mechanism of by-products in existing in vitro transcription reactions is not in-depth enough, especially the production of dsRNA and RNA 3' end extension by-products affects the purity and immunogenicity of mRNA, and existing methods are difficult to effectively remove these by-products.

Method used

Design a repression module that contains hairpin structures that are introduced downstream of the double-stranded DNA template in the in vitro transcription reaction, represses the formation of antisense RNA and dsRNA through the hairpin structure, and introduces corresponding repression modules into the RNA to prevent 3' production of end extension by-products.

Benefits of technology

Effectively reduce or repress the formation of dsRNA and RNA 3’ end extension by-products in in vitro transcription reactions, improve the purity and stability of mRNA, reduce immunogenicity, and simplify the subsequent purification process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004298822170000021
    Figure BDA0004298822170000021
  • Figure BDA0004298822170000031
    Figure BDA0004298822170000031
  • Figure BDA0004298822170000032
    Figure BDA0004298822170000032
Patent Text Reader

Abstract

The present invention provides a repression module for suppressing the formation of byproducts in an in vitro transcription reaction and its application. Specifically, the repression module of the present invention has a hairpin structure design and a base design on both sides of the hairpin structure, and the base sequences on both sides of the hairpin structure cannot be complementary. The repression module is connected to the downstream of the linear double-stranded DNA template, that is, the repression module is located at the 3' end of the double-stranded DNA non-template chain and the 5' end of the DNA template chain. The 3' end of the DNA non-template chain contains a repression module, which can suppress the formation of antisense RNA and dsRNA; the 5' end of the DNA template chain contains a repression module, which promotes the dissociation of the transcription bubble, produces an effect similar to transcription termination, and suppresses the generation of mRNA 3' extension byproducts. In addition, the 3' end of the mRNA transcribed by the IVT reaction also contains a repression module, which can suppress the formation of mRNA 3' extension byproducts.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the fields of biotechnology and nucleic acid medicine, and in particular to a repression module for reducing byproducts in an in vitro transcription reaction and an application thereof. Background Art

[0002] mRNA has broad application prospects as a vaccine and therapeutic drug. mRNA can be translated and assembled into proteins in the human body, and these proteins can be transported to appropriate locations in cells to play a role [1]. Chemical methods for synthesizing mRNA are usually limited to short-chain mRNA (<100 nt). As the length of mRNA increases, the purity and yield of chemically synthesized products decrease significantly, which cannot meet the needs of drug design. Therefore, mRNA is currently mainly transcribed in vitro (IVT) by enzymatic methods, which can achieve mass production of RNA of various lengths. Linear mRNA produced by in vitro transcription is modified by 5' end capping to increase the stability of mRNA and reduce immunogenicity. Circular RNA (circRNA) is a covalently closed single-stranded RNA with no free ends and better stability than linear mRNA. CircRNA has important biological functions and can also translate proteins in the human body, and is used in vaccines and therapeutic drugs. Circular RNA (circRNA) is mainly produced by precursor RNA (pre-mRNA) through variable splicing processing, and precursor RNA is also synthesized by in vitro transcription (IVT) [2].

[0003] Bacteriophage T7 RNA polymerase (T7 RNAP) is a DNA-dependent RNA polymerase that is widely used in in vitro transcription (IVT) to synthesize mRNA and has unique advantages. T7 RNAP is a single-subunit enzyme. Compared with multi-subunit prokaryotic and eukaryotic RNA polymerases, it has a simpler structure, more efficient transcription, and stronger elongation ability [3]. In vitro transcription (IVT) uses a linearized DNA template. T7 RNAP specifically recognizes and binds to the double-stranded T7 promoter sequence, and uses one strand of the double-stranded DNA as a template to catalyze the synthesis of mRNA or precursor RNA from the 5' to 3' direction.

[0004] IVT transcription reactions mainly produce two types of byproducts. One type is RNA 3' end extension byproducts. RNA can bind to T7 RNAP and form a hairpin pairing sequence through intramolecular cis or intermolecular trans base complementary pairing, and continue to extend at the shorter 3' end to produce 3' end extension byproducts [4,5]. The other type is double-stranded RNA (dsRNA) byproducts. T7 RNAP may not rely on the T7 promoter sequence to transcribe the RNA antisense strand, which pairs with the target mRNA product to form dsRNA [6]. However, there is still a lack of in-depth analysis of the formation mechanism of IVT transcription byproducts. The byproducts of the IVT reaction cause mRNA heterogeneity, which will adversely affect the combination of mRNA and lipid molecules to form nanolipid particles (LNPs) [7]. In particular, long-chain dsRNA can induce immune responses in the body. In addition, the production of byproducts consumes nucleotide substrates and reduces mRNA yield.

[0005] mRNA used in vaccines and therapeutic drugs needs to have low immunogenicity, and dsRNA has been shown to be the main factor triggering immune responses [8]. dsRNA can be recognized by intracellular RIG-I-like receptors (RLRs) such as RIG-I and MDA5, inducing the production of type I interferon (IFN) and chemokines, triggering innate immune responses. RIG-I recognizes short-chain dsRNA and dsRNA containing a triphosphate group at the 5' end (5'-ppp-dsRNA). MDA5 recognizes long-chain dsRNA and can also recognize the synthetic dsRNA analog polyinosinic acid (polyI:C). MDA5 is an ATP-dependent helicase. The binding of MDA5 to dsRNA byproducts stimulates ATPase activity and hydrolyzes ATP, which can be analyzed and evaluated through standard biochemical reactions [9,10].

[0006] After the IVT reaction is completed, mRNA needs to be separated and purified to remove byproducts. dsRNA byproducts are difficult to distinguish from mRNA products. Ion-pair reversed-phase high-performance liquid chromatography (HPLC) purification can separate and remove dsRNA, but the production cost is high

[11] . In order to reduce or inhibit the formation of dsRNA byproducts from the source, some literature reports that the use of thermostable T7RNAP mutants in IVT reaction systems at temperatures above 48°C can reduce the formation of dsRNA

[12] . There are also literature exploring the optimization of reaction conditions and adding chaotropic agents such as urea to the IVT system to reduce the formation of dsRNA

[13] .

[0007] Therefore, the formation mechanism of IVT reaction byproducts needs to be further studied in this field, and a method that can effectively reduce or inhibit the formation of dsRNA and RNA 3' end extension byproducts in IVT reactions needs to be developed urgently. Summary of the invention

[0008] The object of the present invention is to provide a repression module in an in vitro transcription reaction, and a method for using the repression module to repress or reduce the formation of RNA byproducts in an in vitro transcription reaction.

[0009] In a first aspect of the present invention, a repression module for suppressing the formation of byproducts in an in vitro transcription reaction is provided, wherein the repression module is located downstream of a double-stranded DNA template in an in vitro transcription reaction system.

[0010] Wherein, the repression module has the structure shown in Formula Ia:

[0011]

[0012] In Formula Ia, the DNA single strand where "5'Z1-Z2-Z3-Z4-Z5 3'" is located is the non-template strand (sense strand); the DNA single strand where "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" is located is the template strand (antisense strand);

[0013] Furthermore, during in vitro transcription, "5'Z1-Z2-Z3-Z4-Z5 3'" in Formula Ia forms a structure shown in Formula Ib from the 5' end to the 3' end:

[0014]

[0015] In Formula Ib, "Z2-Z3-Z4" forms a hairpin structure, wherein Z2 and Z4 are hairpin stems with complementary base pairing, and Z3 is a hairpin loop; Z1 and Z5 are base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1 and Z5 cannot be complementary to each other;

[0016] And, "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" in Formula Ia forms the structure shown in Formula Ib' from the 3' end to the 5' end:

[0017]

[0018] In Formula Ib', "Z2'-Z3'-Z4'" forms a hairpin structure, wherein Z2' and Z4' are the hairpin stems of complementary base pairing, and Z3' is the hairpin loop; Z1' and Z5' are the base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1' and Z5' cannot be complementary to each other;

[0019] In Formula Ia, Formula Ib and Formula Ib', "~" each independently represents a hydrogen bond formed by complementary base pairing; and "-" each independently represents a chemical bond.

[0020] In another preferred embodiment, the formula Ib structure formed by the repression module in the non-template chain can suppress the formation of the first byproduct in the in vitro transcription reaction, wherein the first byproduct is antisense RNA and dsRNA, and the dsRNA is dsRNA formed by complementary pairing of antisense RNA and mRNA.

[0021] In another preferred embodiment, the repression module forms a structure of Formula Ib' in the template chain, which can produce an effect similar to internal termination in the IVT reaction, promote the dissociation of the transcription bubble, and thus repress the 3' extension byproduct (also called transcriptional slippage) produced by the continuous abnormal transcription extension of the DNA template chain;

[0022] The RNA transcribed using the template strand as a template also contains the repressor module, which represses the 3' extension byproduct generated by the self-pairing extension of the RNA;

[0023] That is, the formation of the second byproduct in the in vitro transcription reaction is suppressed, and the second byproduct is the 3'-end extension byproduct of the RNA transcription product (including transcriptional slippage and 3' extension byproduct generated by RNA self-pairing extension).

[0024] In another preferred embodiment, the total length of the repression module is 10-42 bp, preferably 20-30 bp.

[0025] In another preferred embodiment, the repression module The length of the portion is 9-30 bp, preferably 15-20 bp.

[0026] In another preferred embodiment, the total length of Formula Ib or Formula Ib' is 10-42 nt, preferably 20-30 nt.

[0027] In another preferred embodiment, the length of the hairpin structure in Formula Ib or Formula Ib' (ie, Z2-Z3-Z4 or Z2'-Z3'-Z4') is 9-30 nt, preferably 15-20 nt.

[0028] In another preferred embodiment, the length of the hairpin neck in the hairpin structure, ie, Z2 / Z2' or Z4 / Z4', is 3-10 nt.

[0029] In another preferred embodiment, the length of the hairpin loop in the hairpin structure, ie, Z3 / Z3', is 3-10 nt.

[0030] In another preferred embodiment, the length of Z5 / Z5' is at least 1 nt.

[0031] In another preferred embodiment, the length of Z5 / Z5' is 2-6 nt.

[0032] In another preferred embodiment, the Z1 / Z1' is derived from a coding sequence in a double-stranded DNA template.

[0033] In another preferred embodiment, the Z1 / Z1' is derived from a poly(A) sequence in a double-stranded DNA template.

[0034] In another preferred embodiment, the repression module is a non-naturally occurring nucleic acid molecule, including DNA and RNA molecules.

[0035] In another preferred embodiment, the natural DNA and RNA sequences meet the above The features shown can also be matched with sequences that cannot be complementary at both ends (ie, Z1 / Z1' and Z5 / Z5') to be used as a repression module.

[0036] In a second aspect of the present invention, an artificially constructed double-stranded DNA template for in vitro transcription is provided, wherein the double-stranded DNA template has a repression module downstream for suppressing the formation of byproducts in the in vitro transcription reaction, and the double-stranded DNA template has a structure shown in the following formula IIa or IIb:

[0037]

[0038] Wherein, “5’X0-X1-X2-X3 3’” is the non-template strand (sense strand);

[0039] "3'X0'-X1'-X2'-X3'5'" is the template strand (antisense strand)

[0040] X0 / X0' is the promoter sequence;

[0041] X1 / X1' is the target molecule coding sequence in the template;

[0042] X2 / X2' is none or a connection sequence;

[0043] X3 / X3' is a repressor module for suppressing the formation of byproducts in an in vitro transcription reaction, which has a structure as shown in the above formula Ia; wherein during the in vitro transcription process, X3 forms the structure shown in the above formula Ib, and X3' forms the structure shown in the above formula Ib';

[0044] “-” are each independently a chemical bond.

[0045] In another preferred embodiment, when the double-stranded DNA template has the structure shown in IIb, the 3' end of X0 is connected to 0-5 transcription start bases.

[0046] In another preferred embodiment, the promoter is selected from: T7, T3, SP6 promoter or a combination thereof.

[0047] In another preferred embodiment, the X2' is a linker sequence, and the linker sequence is a poly (A) sequence.

[0048] In another preferred embodiment, the by-products include a first by-product and / or a second by-product, wherein the first by-product is antisense RNA and dsRNA, and the dsRNA is a dsRNA formed by complementary pairing of antisense RNA and mRNA; the second by-product is a 3'-end extension by-product of the RNA transcription product (including transcriptional slippage and 3' extension by-product generated by RNA self-pairing extension).

[0049] In another preferred embodiment, the double-stranded DNA template is used to transcribe and generate mRNA and form a precursor RNA (pre-mRNA) of circRNA.

[0050] In a third aspect of the present invention, an RNA molecule formed by in vitro transcription is provided, wherein the 3' end of the RNA molecule contains a repressor module transcribed from a DNA template chain, which can suppress the formation of 3' extension byproducts generated by RNA self-pairing extension, and the RNA molecule has a structure shown in the following formula III from the 5' end to the 3' end:

[0051] Y1-Y2-Y3(III)

[0052] In the formula,

[0053] Y1 is the coding sequence of the RNA molecule;

[0054] Y2 is none or a linking sequence;

[0055] Y3 is a repressor module capable of suppressing the formation of byproducts in an in vitro transcription reaction, and has a structure as shown in the above formula Ib;

[0056] “-” are each independently a chemical bond.

[0057] In another preferred embodiment, the RNA molecule includes mRNA and a precursor RNA (pre-mRNA) that forms a circRNA.

[0058] In another preferred embodiment, when the RNA molecule is mRNA, the linker sequence is a poly (A) sequence.

[0059] A fourth aspect of the present invention provides an in vitro transcription reaction system, the reaction system comprising:

[0060] (1) Pre-reaction system: The pre-reaction system comprises the artificially constructed in vitro transcribed double-stranded DNA template as described in the second aspect of the present invention, and

[0061] (2) Post-reaction system: The post-reaction system contains the RNA molecule formed by in vitro transcription as described in the third aspect of the present invention.

[0062] In another preferred embodiment, the pre-reaction system further contains: RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally RNase inhibitor.

[0063] In another preferred embodiment, the RNA polymerase includes single-subunit and multi-subunit RNA polymerase.

[0064] In another preferred embodiment, the RNA polymerase includes bacteriophage RNA polymerase, bacterial RNA polymerase and eukaryotic RNA polymerase.

[0065] In another preferred embodiment, the bacteriophage RNA polymerase is selected from the following group: T7 RNA polymerase, T3 RNA polymerase, SP6 RNA polymerase, K11 RNA polymerase, Syn5 RNA polymerase or a combination thereof.

[0066] In another preferred embodiment, the bacterial RNA polymerase is selected from the following group: E. coli RNA polymerase, T. thermophiles RNA polymerase, or a combination thereof.

[0067] In another preferred embodiment, the eukaryotic RNA polymerase includes yeast RNA polymerase and mammalian RNA polymerase.

[0068] In another preferred embodiment, the post-reaction system contains almost no in vitro transcription reaction by-products, including first by-products and / or second by-products, wherein the first by-products are antisense RNA and dsRNA, and the dsRNA is dsRNA formed by complementary pairing of antisense RNA and mRNA; the second by-product is a 3'-end extension by-product of the RNA transcription product (including transcriptional slippage and 3' extension by-products generated by RNA self-pairing extension).

[0069] In another preferred embodiment, the “almost no in vitro transcription reaction byproducts” means that the in vitro transcription reaction byproducts in the post-reaction system cannot be effectively detected.

[0070] A fifth aspect of the present invention provides an in vitro transcription reaction kit, the kit comprising:

[0071] (c1) reaction reagents, which include the artificially constructed in vitro transcribed double-stranded DNA template as described in the second aspect of the present invention, RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally an RNase inhibitor; and

[0072] (c2) Instructions.

[0073] In another preferred embodiment, the reaction reagent is a liquid reagent or a freeze-dried reagent.

[0074] In another preferred embodiment, the reaction reagents are disposed in a plurality of containers.

[0075] In another preferred embodiment, the instructions indicate that the kit is used to transcribe and produce mRNA or circRNA.

[0076] In another preferred embodiment, the reaction reagents optionally further include reagents required for self-cleavage and circularization of the precursor RNA of circRNA.

[0077] The sixth aspect of the present invention provides a use of the in vitro transcription reaction system as described in the fourth aspect of the present invention or the in vitro transcription reaction kit as described in the fifth aspect of the present invention, for producing RNA molecules in vitro.

[0078] In another preferred embodiment, the RNA molecule includes mRNA and circRNA.

[0079] In another preferred embodiment, the RNA molecule is used to prepare RNA preparations, including (but not limited to) mRNA therapeutic drugs, mRNA vaccines, circRNA therapeutic drugs, and circRNA vaccines.

[0080] The seventh aspect of the present invention provides an in vitro transcription method, the method comprising the steps of:

[0081] The in vitro transcription reaction is performed using the in vitro transcription reaction system as described in the fourth aspect of the present invention, or the in vitro transcription reaction kit as described in the fifth aspect of the present invention.

[0082] In another preferred embodiment, the in vitro transcription method effectively suppresses the formation of by-products in the in vitro transcription reaction.

[0083] In another preferred embodiment, the by-products include the first by-product and / or the second by-product, wherein the first by-product is antisense RNA and dsRNA, and the dsRNA is dsRNA formed by complementary pairing of antisense RNA and mRNA; the second by-product is a 3'-end extension by-product of RNA transcription product (including transcriptional slippage and 3' extension by-product generated by RNA self-pairing extension).

[0084] In an eighth aspect of the present invention, a method for preparing a target mRNA molecule in vitro is provided, the method comprising the steps of:

[0085] (i) providing a double-stranded DNA template encoding a target mRNA molecule, wherein the double-stranded DNA template contains the repression module as described in the first aspect of the present invention;

[0086] (ii) performing an in vitro transcription reaction using the double-stranded DNA template described in step (i) to obtain a crude target mRNA molecule product.

[0087] In another preferred embodiment, the method further comprises step (iii): purifying the crude target mRNA molecule obtained in step (ii) to obtain the target mRNA molecule.

[0088] In another preferred embodiment, the target mRNA molecule can be used to prepare mRNA therapeutic drugs or mRNA vaccines.

[0089] The ninth aspect of the present invention provides a method for preparing a target cricRNA molecule in vitro, the method comprising the steps of:

[0090] (a) providing a double-stranded DNA template encoding a target circRNA molecule, wherein the double-stranded DNA template contains the repression module described in the first aspect of the present invention;

[0091] (b) performing an in vitro transcription reaction using the double-stranded DNA template described in step (a) to obtain a precursor RNA (pre-mRNA) of the target circRNA molecule;

[0092] (c) The precursor RNA (pre-mRNA) in step (b) undergoes self-cleavage and circularization to form a crude product of the target circRNA molecule.

[0093] In another preferred embodiment, the method further comprises step (d): purifying the crude target circRNA molecule obtained in step (c) to obtain the target circRNA molecule.

[0094] In another preferred embodiment, the target circRNA molecule can be used to prepare circRNA therapeutic drugs or circRNA vaccines.

[0095] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS

[0096] Figure 1The double-stranded DNA template in the IVT reaction is shown, which contains a T7 promoter sequence (in the box) and a repressor module. As shown in sequence 1 and sequence 2, the repressor module is located at the 3' end of the double-stranded DNA non-template strand (SEQ ID NO: 57; 59) and the 5' end of the template strand (SEQ ID NO: 58; 60), and includes a hairpin structure (the hairpin stem indicated by the dashed line above the sequence, and the hairpin loop indicated by the dotted line above the sequence), and the base sequences at both ends of the hairpin structure (underlined), and the bases at both ends cannot be complementary. The repressor module can be added downstream of any linear template or in a poly (A) sequence. The base sequence at the 3' end of the hairpin of the repressor module in the sequence 3 mRNA sequence (SEQ ID NO: 61), especially the terminal base, cannot form complementary pairing in cis.

[0097] Figure 2 The double-stranded DNA template contains a repressor module, including a hairpin structure and the base sequence design at both ends of the hairpin structure, which can repress the formation of antisense RNA and dsRNA byproducts, and can also repress the formation of mRNA 3' extension byproducts. In the figure, (1-1) and (1-2) represent T7 RNA polymerase (T7RNAP); (2) represents linear double-stranded DNA, containing a T7 promoter sequence (2-0), and the DNA template chain, i.e., the T7RNAP transcription template chain, contains a repressor module indicated by an arrow (2-T), which promotes the dissociation of the transcription bubble, produces an effect similar to transcription termination, and represses the production of mRNA 3' extension byproducts. The DNA non-template chain contains a repressor module (2-NT) indicated by an arrow, which represses the transcription of the 3' end of the non-template chain that is independent of the T7 promoter, that is, it represses the formation of antisense RNA and dsRNA; (3) is the mRNA product formed by T7RNAP transcribing the DNA template chain, containing a repressor module (3-R) indicated by an arrow, including a hairpin structure (3-1) and the base design at both ends of the hairpin (3-2) and (3-3), (3-3) and (3-2) bases cannot form complementary pairing, or the terminal base of (3-3) cannot pair with its own mRNA, thereby repressing the extension of the 3' end of the mRNA.

[0098] Figure 3The figure shows the hypothesis that the 3' end of the non-template strand is not dependent on the T7 promoter for transcription in a single-cycle IVT reaction, with linear double-stranded DNA A40, A38, A35, and A31 as templates. The 3' end of the template strand (SEQ ID NO: 63, 65, 67, and 69) has an extended sequence and a biotin label, and the non-template strand (SEQ ID NO: 62, 64, 66, and 68) is annealed and paired with the template strand, and the double-stranded DNA is coupled to the SA magnetic beads through the biotin label at the 3' end of the template strand. The gray ellipse represents T7RNAP binding to the template strand to form a transcription bubble for transcription. In the first transcription reaction, the nucleotides in the system are only GTP and ATP, and the reaction stops when the mismatch base (mismatch AA) is reached; in the second transcription reaction, the excess T7RNAP and nucleotides in the system are removed, and UTP and ATP are added. The T7RNAP bound to the template allows the transcription reaction to continue. When the transcription reaches the 3' end of the mRNA, the reaction stops for the second time because there is no CTP in the system. In the third transcription reaction, T7RNAP, fluorescently labeled UTP, and GTP are added. When the reaction is finished, the presence of antisense RNA, that is, whether the non-template chain is transcribed, is determined by scanning the fluorescent signal on the electrophoresis gel.

[0099] Figure 4 The results of the single-cycle IVT experiment showed that the 3' end of the non-template chain was transcribed independently of the T7 promoter to form antisense RNA containing fluorescently labeled UTP (Alexa647-UTP). Among them, lane 1. A31 template, single-cycle IVT reaction, no antisense RNA was formed; lane 2. A35 template, single-cycle IVT reaction, no antisense RNA was formed; lane 3. A38 template, single-cycle IVT reaction, no antisense RNA was formed; lane 4. A40 template, single-cycle IVT reaction, non-template chain transcription formed antisense RNA.

[0100] Figure 5 The graph shows the IVT reactions using linear DNA containing a promoter (SEQ ID NOs: 93, 94) and the corresponding mRNA product (SEQ ID NO: 1) as templates, and the generation of by-products and their pattern characteristics over time. Figure 6 This indicates that the transcription of the DNA template chain in the IVT reaction was not terminated in time, resulting in an abnormal 3'-end extension byproduct (transcriptional slippage) that was longer than expected.

[0101] Figure 7 The results show that the IVT reaction with T7RNAP using poly(A) or poly(U) RNA sequences (SEQ ID NO: 72, 95) as templates did not produce 3'-end extension byproducts.

[0102] Figure 8It shows that the single-subunit T7RNAP, multi-subunit E.coli RNAP, and T.thermophilus RNAP all react with mRNA-T2 single-stranded RNA as template to form 3'-end extension products. Among them, lanes 1, 2, 3, and 4, IVT reaction temperature is 37℃; lanes 1', 2', 3', and 4' IVT reaction temperature is 50℃; arrows indicate 3'-end extension products: lane 1, lane 1', mRNA-T2 control, the reaction system does not have RNA polymerase; lane 2, lane 2', T7RNAP 3'-end extension reaction with mRNA-T2 as template; lane 3, lane 3', E.coli RNAP 3'-end extension reaction with mRNA-T2 as template; lane 4, lane 4', T.thermophilus RNAP 3'-end extension reaction with mRNA-T2 as template.

[0103] Fig. 9 The 3'-end extension reaction of T7RNAP, E.coli RNAP, and T.thermophilus RNAP using different single-stranded RNA as templates is shown. When the 3'-end of mRNA forms a hairpin structure, adding non-paired bases at the 3'-end of the hairpin can inhibit the formation of 3'-end extension products. Among them, A.mRNA-T2.1, B.mRNA-T2.2, C.mRNA-T2.3, D.M512-HP, and E.Poly(A)-HP; Lane 1 is a single-stranded RNA control, Lane 2 is a 3'-end extension reaction catalyzed by T7RNAP, Lane 3 is a 3'-end extension reaction catalyzed by E.coli RNAP, and Lane 4 is a 3'-end extension reaction catalyzed by T.thermophilus RNAP.

[0104] Fig.10 The 3'-end extension reaction of T7 RNAP (A), E. coli RNAP (B), and T. thermophilus RNAP (C) using single-stranded RNA as template shows the effect of the number of unpaired bases connected by the hairpin structure in the poly (A) sequence of RNA on the 3'-end extension product. Lane 1: Poly (A)-HP5 (SEQ ID NO: 6); 2: Poly (A)-HP0 (SEQ ID NO: 7); 3: Poly (A)-HP1 (SEQ ID NO: 8); 4: Poly (A)-HP2 (SEQ ID NO: 9); 5: Poly (A)-HP3 (SEQ ID NO: 10); 6: Poly (A)-HP4 (SEQ ID NO: 11).

[0105] Fig.11The 3'-end extension reaction of T7RNAP (A), E.coli RNAP (B), and T.thermophilus RNAP (C) using RNA-HP-stem (3-9 hairpin neck stem bases, no 3'-end unpaired bases; SEQ ID NO: 12-18) as template is shown, wherein lane 1. RNA-HP-stem03; 2. RNA-HP-stem04; 3. RNA-HP-stem05; 4. RNA-HP-stem06; 5. RNA-HP-stem07; 6. RNA-HP-stem08; 7. RNA-HP-stem09; + represents the addition of RNA polymerase to the reaction system; - represents the control without RNA polymerase.

[0106] Fig.12 It shows the 3'-end extension reaction of T7RNAP (A), E.coli RNAP (B), and T.thermophilus RNAP (C) using RNA-HP-loop (2-16 Loop bases, SEQ ID NO: 19-25) as template, wherein lane 1. RNA-HP-loop02; 2. RNA-HP-loop03; 3. RNA-HP-loop04; 4. RNA-HP-loop07; 5. RNA-HP-loop10; 6. RNA-HP-loop13; 7. RNA-HP-loop16.

[0107] Fig.13 It shows that the RNA sequence A5-HP (SEQ ID NO: 26) containing a hairpin structure can resist ExoT enzymatic degradation; the AC-5 RNA sequence (SEQ ID NO: 27) without a hairpin structure is degraded by ExoT. Lanes 1-6 are the ExoT enzymatic reactions of A5-HP RNA, and the amount of ExoT enzyme increases from low to high (from 0 to 0.133U / ul) by 3 times; lanes 1'-6' are the ExoT enzymatic reactions of AC-N RNA, and the amount of ExoT enzyme increases from low to high (from 0 to 0.133U / ul) by 3 times.

[0108] Fig.14The IVT products were analyzed by electrophoresis (15% polyacrylamide urea gel) after T7 RNAP transcribed T7-HP-A series (Note 2) linear double-stranded DNA templates (introducing hairpin structures and different numbers of unpaired bases at the 3' end in the polyA sequence). Run-off products are target transcription products, which start transcription from the G bases at the +1 and +2 positions after the T7 promoter, respectively. Lanes 1-9 correspond to templates SEQ ID NO:28-36, whose 3' ends connected by hairpin structures contain 0-8 unpaired bases, respectively. Lane 10 is the IVT product of T7-HP-AC (SEQ ID NO:37) poly(A) template without hairpin structure.

[0109] Fig.15 8 groups of linear DNA templates containing T7 promoter sequences (SEQ ID NO: 73-86) are shown, and their hairpin structures contain hairpin necks (stem bases, indicated by dotted lines above the sequences) of different lengths. The 8 groups of DNA templates contain the same 4-base hairpin loop (loop) (indicated by dotted lines above the black font sequence) sequence, and the hairpin necks (Stem) have different lengths, containing 8 to 1 base paired Stem, respectively, and the 3' end of the hairpin neck is connected to 5 unpaired bases A.

[0110] Fig.16 Show ExoT digestion Fig.15 The IVT product mRNA of the DNA template shown in the gel image shows the stability of mRNA against ExoT digestion. The 1-8 marked in the figure represent the hairpin neck stem containing 1 to 8 paired bases in the mRNA.

[0111] Fig.17 It shows that the polyA sequences of linear DNA templates of different lengths (47, 55, 65, 75mer) contain repression modules (IM), and the IVT reaction can obtain transcription products of a certain length, while the products of the IVT reaction of the DNA templates without the repression module contain a large number of by-products, and no transcription products of a certain length are observed; among them, lane 1. T7-IM-47 (SEQ ID NO: 38), 2. T7-polyA-47 (SEQ ID NO: 39), 3. T7-IM-55 (SEQ ID NO: 40), 4. T7-IM-65 (SEQ ID NO: 41), 5. T7-IM-75 (SEQ ID NO: 42).

[0112] Fig.18The 512B series DNA template sequences are shown. T7pro-512B (containing the underlined T7 promoter) (SEQ ID NO: 87), 512B (without the T7 promoter) (SEQ ID NO: 88) sequences are from reference [6]; T7p-512B-T7p (SEQ ID NO: 91) template contains T7 promoters at both ends. T7pro-512B1, T7pro-512B2, T7pro-512B-HP1, T7pro-512B-HP2 (SEQ ID NO: 89, 90, 92, 96) four sequences contain repression modules, including the hairpin structure indicated by italics and underline ( CCCGCTTCGGCGGG ) and the unpaired base at the 3' end of the hairpin.

[0113] Fig.19 The results show the detection of dsRNA in the IVT reaction products after applying the repressor module to the 512B series DNA template. The sequence characteristics of the DNA template corresponding to each lane are listed in Table 6. A. 5% TBE gel electrophoresis, 500 ng IVT product loading; the results of lanes 1 and 2 are consistent with the literature [6], lanes 3, 4, 6, and 7, the linear DNA template contains the repressor module, and no dsRNA is detected in the IVT product, and lane 5, both ends of the DNA template contain T7 promoters, and dsRNA is detected. B. Dotblot (dsRNADetector kit) detection of dsRNA, the IVT product loading amounts are 100 ng, 50 ng, 20 ng and 10 ng respectively; a small amount of dsRNA is detected in 100 ng IVT product in lane 1, lanes 2 and 5, dsRNA is the main product, and lanes 3, 4, 6, and 7, the template contains the repressor module, and no dsRNA is detected in the IVT product. C. HPLC purification profile, separation of mRNA (Fraction II) and dsRNA (Fraction III) in IVT products. Fig. 20 The figure shows the MDA5-ΔN ATPase experiment to detect dsRNA in the IVT reaction products of the 512B series templates; wherein column 1 is a blank control (without MDA5-ΔN), column 2 is the IVT product of the 512B template (SEQ ID NO: 88), column 3 is the IVT product of the T7p-512B-T7p template (SEQ ID NO: 91), column 4 is the IVT product of the 512B-HP1 template (SEQ ID NO: 92), and column 5 is the IVT product of the 512B-HP2 template (SEQ ID NO: 96).

[0114] Fig.21The dual luciferase reporter system driven by the IFNβ promoter in HEK293T cells is shown. The cells express the MDA5 receptor, which binds to the byproduct dsRNA in the cell transfected RNA, stimulating the signaling pathway and reporter gene expression. Among them, column 1. negative control; column 2. polyI:C polyinosinic acid; column 3. IVT product of 512B template (SEQ ID NO: 88); column 4. IVT product of T7p-512B-T7p template (SEQ ID NO: 91); column 5. IVT product of 512B-HP1 template (SEQ ID NO: 92); column 6. IVT product of 512B-HP2 template (SEQ ID NO: 96).

[0115] Fig. 22 The 5% TBE gel electrophoresis gel and Dotblot images are shown for detecting dsRNA in IVT products with EGFP linear DNA as template. The 3' end sequences of the three EGFP templates (SEQ ID NO:43) in lanes 1, 2, and 3 are [seq1], [poly(A)-IM], and [33poly(A)] (SEQ ID NO:44, 45, 46), respectively. A. 5% TBE gel electrophoresis, 500 ng IVT product loading; Lane 2 contains the EGFP template IVT product with the repressor module [poly(A)-IM], which has the lowest dsRNA content. B. Dotblot (dsRNADetector kit) detection of dsRNA, the IVT product loading amounts are 400 ng, 133 ng, 44 ng, and 14.8 ng, respectively; Lane 2, the EGFP template IVT product with the repressor module [poly(A)-IM] contains the lowest dsRNA content.

[0116] Fig.23 The figure shows the expression of EGFP after mRNA transfection in Expi293 cells detected by FACS. When the transfection amount is the same, the EGFP expression levels of D and C, and F and E are comparable, that is, the EGFP expression levels of mRNA containing the repression module and mRNA containing only poly(A) are comparable. A. Blank (untransfected mRNA); B. uncapped mRNA; C. Capped mRNA [43Poly(A)] (SEQ ID NO: 47); D. Capped mRNA [43Poly(A)-IM] (SEQ ID NO: 49); E. Capped mRNA [53Poly(A)] (SEQ ID NO: 48); F. Capped mRNA [53Poly(A)-IM] (SEQ ID NO: 50).

[0117] Fig.24The effect of group I intron self-cleavage and dsRNA on RNA cyclization is shown. Seq-Full-length (SEQ ID NO:55) in Note 3 is a template from the literature

[27] , and the sequence contains a lot of secondary structures. A. The truncated sequence of seq-truncate 1,2,3 (SEQ ID NO:51-53) in Note 3 is used as a linear DNA template. The product was purified after IVT reaction by 5% TBE gel electrophoresis and AO staining; when the DNA template is seq-truncate 1,2,3, the dsRNA indicated by the arrow can be observed in lanes 1', 2', and 3' of the IVT product. When the sequence in the box of the DNA template seq-truncate 1,2,3 is replaced by the repressor module [IM] (SEQ ID NO:54), lanes 1, 2, and 3 show that no dsRNA is observed in the IVT product. B. RNA self-cleavage circularization, lane 1. Seq-Full-length, 2. Seq-Full-length [IM] (the sequence in the box of Seq-Full-length is replaced by the repression module [IM] (SEQ ID NO: 54)), 3. Seq-Full-length [T7p] (the sequence in the box of Seq-Full-length is replaced by [T7p] (SEQ ID NO: 56)). C. Self-cleavage circularization using circRNA-RBD-template as template (sequence from reference

[28] ), lane 1. circRNA-RBD-template, 2. circRNA-RBD-template [IM], 3. circRNA-RBD-template [T7p].

[0118] Fig.25 The following are schematic diagrams showing the mechanism of IVT reaction byproduct production discovered by the present invention and the schematic diagram of the repression module of the present invention designed for the mechanism. A. Schematic diagram of the mechanism of IVT reaction byproduct production. B. Schematic diagram of the repression module of the present invention exerting a repression effect.

[0119] Fig.26 The transcription extension process in different situations in the IVT reaction is shown. A. The transcription extension process of the linear DNA template in the IVT reaction; B. The 3' extension process of the mRNA itself cis-complementary. DETAILED DESCRIPTION

[0120] The present invention verifies that T7 RNAP can combine with DNA non-template strands to produce transcription that is independent of T7 promoters, produce antisense RNA, and then form long-chain dsRNA through single-cycle IVT experimental design. At the same time, by designing the DNA template sequence and adopting the polyA sequence, the production of byproducts by mRNA self-pairing is excluded, and the production of antisense RNA is excluded by the selective addition of nucleotides, and a unique 3' extension byproduct formation mechanism of the IVT reaction is found, that is, T7 RNAP fails to fall off from the end of the DNA template strand in time, and when T7 RNAP is complexed with the DNA template and RNA product (i.e., transcription bubble), a 3' extension byproduct (transcriptional slippage) is produced. The present invention also explores and verifies the mechanism of cis-complementation of transcription RNA products to produce 3' extension byproducts.

[0121] Based on the above-mentioned research on the formation mechanism of IVT reaction byproducts, in order to inhibit the formation of byproducts at the source, the present invention introduces a repression module downstream of the double-stranded linear DNA template, including a hairpin structure (HP) and the base design on both sides of the hairpin structure, so that the base sequences on both sides of the hairpin cannot form base complementarity, or cannot effectively complement each other, or the 3' end bases of the hairpin cannot form cis complementary pairing. When the linear DNA template contains a poly (A) tail, the repression module is introduced into the poly (A) tail, and the 3' end of the hairpin structure of the DNA non-template chain is preferably connected to 1-6 adenine bases A, and the 5' end of the hairpin structure of the DNA template chain is connected to 1-6 thymine bases T. The DNA template chain introduced with the repression module can produce an effect similar to internal termination (intrinsic termination like) [14,15], dissociate the transcription bubble, and terminate transcription in time, thereby inhibiting the formation of 3' end extension byproducts and obtaining mRNA with expected length and high uniformity. The RNA transcribed from the DNA template strand also contains a repressor module, which can suppress the RNA cis-complementary pairing to produce a 3'-end extension byproduct. At the same time, the repressor module can also suppress the DNA non-template strand from being transcribed from the 3' end without a promoter sequence, suppressing the formation of the byproduct RNA antisense strand, that is, suppressing the antisense RNA and mRNA complementary pairing to form a dsRNA byproduct. On this basis, the present invention is completed.

[0122] the term

[0123] In order that the present disclosure may be more readily understood, certain terms are first defined. As used in this application, unless otherwise expressly provided herein, each of the following terms shall have the meaning given below.

[0124] Throughout the specification, the word "comprise" or variations such as "comprising" or "containing" will be understood to mean the inclusion of stated elements, integers or steps, or groups of elements, integers or steps, but not the exclusion of any other elements, integers or steps, or groups of elements, integers or steps.

[0125] Unless otherwise stated or apparent from the context, as used herein, the term "about" should be understood to be within the normal tolerance range in the art, such as within 2 standard deviations of the mean. "About" can be understood to be within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, 0.01% or 0.001% of the stated value. Unless otherwise indicated in the context, all numerical values ​​provided herein reflect normal fluctuations that can be understood by a skilled person.

[0126] As used herein, the term "in vitro" refers to events that occur in an artificial environment, such as in a test tube or reaction vessel, in cell culture, etc., rather than in a multicellular organism.

[0127] As used herein, the term "in vivo" refers to events that occur within multicellular organisms such as humans and non-human animals. In the context of cell-based systems, the term can be used to refer to events that occur within living cells (as opposed to, for example, in vitro systems).

[0128] As used herein, the term "nucleic acid" refers to any compound and / or substance that is incorporated or can be incorporated into a polynucleotide chain in its broadest sense. In some embodiments, nucleic acid is a compound and / or substance that is incorporated into or can be incorporated into a polynucleotide chain by a phosphodiester bond. In some embodiments, "nucleic acid" refers to a single nucleic acid residue (e.g., nucleotides and / or nucleosides). In some embodiments, "nucleic acid" refers to a polynucleotide chain comprising a single nucleic acid residue. In some embodiments, "nucleic acid" encompasses RNA and single-stranded and / or double-stranded DNA and / or cDNA. In addition, the terms "nucleic acid", "DNA", "RNA" and / or similar terms include nucleic acid analogs, i.e., analogs with a phosphodiester backbone. Unless otherwise specified, nucleic acid sequences are presented in a 5' to 3' direction.

[0129] As used herein, "transcription" of a nucleic acid sequence refers to the production of RNA from a DNA sequence (eg, by in vitro transcription) and / or the processing of an RNA transcript (eg, by splicing, editing, 5' cap formation and / or 3' end formation).

[0130] As used herein, "expression" of a nucleic acid sequence refers to the translation of RNA into a polypeptide or protein; and / or post-translational modification of the polypeptide or protein.

[0131] As used herein, the term "messenger RNA (mRNA)" refers to a polynucleotide encoding at least one polypeptide. As used herein, mRNA encompasses both modified and unmodified RNA. mRNA may contain one or more coding and non-coding regions. mRNA may be purified from natural sources, using in vitro transcription or chemical synthesis. Where appropriate, for example, in the case of chemically synthesized molecules, mRNA may contain nucleoside analogs, such as analogs with chemically modified bases or sugars, backbone modifications, etc. Unless otherwise indicated, the display direction of mRNA sequences is 5' to 3'.

[0132] mRNA is generally considered to be the type of RNA that transmits information from DNA to the ribosome. The existence of mRNA is usually very short-lived and includes processing and translation, followed by degradation. Typically, in eukaryotic organisms, mRNA processing includes the addition of a "cap" at the N (5') terminus, and a "tail" at the C (3') terminus. The typical cap is a 7-methylguanosine cap, which is a guanosine attached to the first transcribed nucleotide via a 5'5' triphosphate bond. The presence of the cap is important for providing resistance to nucleases present in most eukaryotic cells. The tail is usually a polyadenylation event, whereby a poly A portion is added to the 3' end of the mRNA molecule. The presence of this "tail" serves to protect the mRNA from exonuclease degradation. Messenger RNA is typically translated by the ribosome into a series of amino acids that make up proteins.

[0133] As used herein, the term "template DNA" (or "DNA template") generally relates to a DNA molecule comprising a nucleic acid sequence encoding an mRNA transcript to be synthesized by in vitro transcription. The template DNA is used as a template for in vitro transcription to produce an mRNA transcript encoded by the template DNA. The template DNA comprises all elements necessary for in vitro transcription, in particular a promoter element for binding to a DNA-dependent RNA polymerase, such as a promoter element recognized by T3, T7, and SP6 RNA polymerases, which is operably linked to a DNA sequence encoding the desired mRNA transcript. In addition, the template DNA may comprise a 5' and / or 3' primer binding site of the DNA sequence encoding the mRNA transcript, in order to determine the identity of the DNA sequence encoding the mRNA transcript, for example by PCR or DNA sequencing. "Template DNA" in the context of the present invention is a linear double-stranded DNA molecule.

[0134] Repression module

[0135] In one aspect of the present invention, a repression module is provided. As used herein, the term "repression module" refers to a nucleic acid sequence used to suppress or reduce the formation of byproducts in an in vitro transcription reaction, which has a hairpin structure design and a base design on both sides of the hairpin structure, and the base sequences on both sides of the hairpin structure cannot be complementary; and the nucleic acid sequence is connected to the downstream of the linear double-stranded DNA template in the in vitro transcription reaction system. During in vitro transcription, the repression module suppresses the formation of antisense RNA and dsRNA (i.e., the first byproduct) by forming a hairpin structure at the 3' end of the DNA non-template strand; at the same time, the repression module sequence at the 5' end of the DNA template strand can promote timely termination of transcription and suppress the abnormal continuous transcription of the DNA template strand to produce a 3' end extension byproduct; in addition, the 3' end of the mRNA transcribed by the IVT reaction contains a corresponding repression module, which can suppress the 3' extension of the mRNA cis complementary pairing; thereby suppressing the formation of the 3' end extension byproduct (i.e., the second byproduct).

[0136] Specifically, the repression module has the structure shown in Formula Ia:

[0137]

[0138] In Formula Ia, the DNA single strand where "5'Z1-Z2-Z3-Z4-Z5 3'" is located is the non-template strand (sense strand); the DNA single strand where "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" is located is the template strand (antisense strand);

[0139] Furthermore, during in vitro transcription, "5'Z1-Z2-Z3-Z4-Z5 3'" in Formula Ia forms a structure shown in Formula Ib from the 5' end to the 3' end:

[0140]

[0141] In Formula Ib, "Z2-Z3-Z4" forms a hairpin structure, wherein Z2 and Z4 are hairpin stems with complementary base pairing, and Z3 is a hairpin loop; Z1 and Z5 are base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1 and Z5 cannot be complementary to each other;

[0142] And, "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" in Formula Ia forms the structure shown in Formula Ib' from the 3' end to the 5' end:

[0143]

[0144] In Formula Ib', "Z2'-Z3'-Z4'" forms a hairpin structure, wherein Z2' and Z4' are the hairpin stems of complementary base pairing, and Z3' is the hairpin loop; Z1' and Z5' are the base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1' and Z5' cannot be complementary to each other;

[0145] In Formula Ia, Formula Ib and Formula Ib', "~" each independently represents a hydrogen bond formed by complementary base pairing; and "-" each independently represents a chemical bond.

[0146] The total length of the repression module is 10-42 bp, preferably 20-30 bp, wherein The length of the part is 9-30bp, preferably 15-20bp; the total length of Formula Ib or Formula Ib' is 10-42nt, preferably 20-30nt; the length of the hairpin structure (i.e., Z2-Z3-Z4 or Z2'-Z3'-Z4') in Formula Ib or Formula Ib' is 9-30nt, preferably 15-20nt; the length of the hairpin neck in the hairpin structure, i.e., Z2 / Z2' or Z4 / Z4', is 3-10nt; the length of the hairpin loop in the hairpin structure, i.e., Z3 / Z3', is 3-10nt; the length of the Z5 / Z5' is at least 1nt, for example 2-6nt.

[0147] Furthermore, the present invention also provides an artificially constructed double-stranded DNA template for in vitro transcription, wherein the downstream of the double-stranded DNA template carries a repression module for suppressing the formation of byproducts in the in vitro transcription reaction, wherein the byproducts include a first byproduct and / or a second byproduct, wherein the first byproduct is antisense RNA and dsRNA, wherein the dsRNA is a dsRNA formed by complementary pairing of antisense RNA and mRNA; and the second byproduct is a 3'-end extension byproduct of the RNA transcription product (including transcriptional slippage and 3' extension byproduct generated by RNA through self-pairing extension). And an RNA molecule formed by in vitro transcription of the double-stranded DNA template, wherein the 3' end of the RNA molecule contains a repression module transcribed from the template strand in the double-stranded DNA template, which can suppress the formation of 3' extension byproducts generated by RNA through self-pairing extension.

[0148] In vitro transcription reaction system of the present invention

[0149] In another aspect of the present invention, an in vitro transcription reaction system is provided. In the present invention, the "in vitro transcription reaction system" includes: (1) a pre-reaction system, wherein the pre-reaction system contains the artificially constructed in vitro transcription double-stranded DNA template as described in the second aspect of the present invention, as well as RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally contains an RNase inhibitor. Further, the "in vitro transcription reaction system" also includes: (2) a post-reaction system, wherein the post-reaction system contains the RNA molecule formed by in vitro transcription as described in the third aspect of the present invention, that is, the RNA molecule generated after the in vitro transcription reaction of the artificially constructed in vitro transcription double-stranded DNA template. In addition, the post-reaction system contains almost no in vitro transcription reaction byproducts, including the first byproduct (antisense RNA and dsRNA) and / or the second byproduct (3' end extension byproduct of the RNA transcription product).

[0150] The term "almost free of in vitro transcription reaction byproducts" means that the in vitro transcription reaction byproducts in the system after the reaction cannot be effectively detected, for example, no readable bands can be detected by electrophoresis.

[0151] The RNA polymerases that can be used in the in vitro transcription reaction system of the present invention to transcribe the double-stranded DNA template include single-subunit and multi-subunit RNA polymerases; the RNA polymerases include bacteriophage RNA polymerases, bacterial RNA polymerases and eukaryotic RNA polymerases. Among them, the bacteriophage RNA polymerases include (but are not limited to) T7 RNA polymerase, T3 RNA polymerase, SP6 RNA polymerase, K11 RNA polymerase, Syn5 RNA polymerase; the bacterial RNA polymerases include (but are not limited to) E. coli RNA polymerase, T. thermophiles RNA polymerase; the eukaryotic RNA polymerases include (but are not limited to) yeast RNA polymerases and mammalian RNA polymerases. In some embodiments, the concentration of the RNA polymerase in the in vitro transcription reaction system can be about 1 to 100 nM, 1 to 90 nM, 1 to 80 nM, 1 to 70 nM, 1 to 60 nM, 1 to 50 nM, 1 to 40 nM, 1 to 30 nM, 1 to 20 nM or about 1 to 10 nM.

[0152] The concentration of each ribonucleotide (e.g., ATP, UTP, GTP, and CTP) in the in vitro transcription reaction system is about 0.1 mM to about 10 mM. In some embodiments, the total concentration range of rNTPs (e.g., a combination of ATP, GTP, CTP, and UTP) in the in vitro transcription reaction system is between 1 mM and 30 mM. In a specific embodiment, the concentration of each rNTP in the reaction mixture is optimized based on the frequency of each nucleic acid in the nucleic acid sequence encoding a given mRNA transcript. Specifically, the reaction mixture of this sequence optimization comprises a certain proportion of each of the four rNTPs (e.g., ATP, GTP, CTP, and UTP) corresponding to the proportion of these four nucleic acids (A, G, C, and U) in the mRNA transcript.

[0153] The in vitro transcription reaction buffer typically includes salts / buffers such as Tris, HEPES, ammonium sulfate, sodium bicarbonate, sodium citrate, sodium acetate, potassium phosphate, sodium phosphate, sodium chloride, and magnesium chloride.

[0154] The pH of the in vitro transcription reaction system may be between about 6 and 8.5, 6.5 and 8.0, 7.0 and 7.5, and in some embodiments, the pH is 7.4.

[0155] In vitro transcription reaction kit of the present invention

[0156] In another aspect of the present invention, an in vitro transcription reaction kit is provided, the kit comprising: (c1) reaction reagents, the reagents comprising the artificially constructed in vitro transcription double-stranded DNA template as described in the second aspect of the present invention, RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally an RNase inhibitor; and (c2) instructions.

[0157] The reaction reagents may be provided in liquid form or in freeze-dried form; each reaction reagent may be disposed in several separate containers or in the same container in the form of a reagent mixture; preferably, each reaction reagent is disposed in several separate containers and provided separately.

[0158] The specification indicates that the kit is used to transcribe and produce mRNA or circRNA. When used to transcribe and produce circRNA, the reaction reagents also include reagents required for self-cleavage and cyclization of the precursor RNA of the circRNA. Further, the specification also records a method for using the kit for in vitro transcription reaction: each reaction reagent, including a double-stranded DNA template (its amount / concentration is sufficient to provide the required amount of RNA), RNA polymerase, NTPs, in vitro transcription reaction buffer and RNase inhibitor are mixed to form a reaction mixture, and the reaction mixture is incubated at about 37°C and about 56°C for 30 minutes to 6 hours, for example, about 60 minutes to about 90 minutes. In some embodiments, the reaction mixture is incubated at about 37°C to about 42°C for about 60 minutes to about 90 minutes.

[0159] Methods and Applications

[0160] The present invention also provides an in vitro transcription method and a method for preparing target RNA molecules (including mRNA and circRNA) in vitro.

[0161] The in vitro transcription method of the present invention comprises using the in vitro transcription reaction system (herein referred to as the pre-reaction system) as described in the fourth aspect of the present invention, or the in vitro transcription reaction kit as described in the fifth aspect of the present invention to perform an in vitro transcription reaction.

[0162] The method for preparing a target mRNA molecule in vitro of the present invention comprises the following steps:

[0163] (i) providing a double-stranded DNA template encoding a target mRNA molecule, wherein the double-stranded DNA template contains the repression module as described in the first aspect of the present invention; (ii) using the double-stranded DNA template described in step (i) to perform an in vitro transcription reaction to obtain a crude target mRNA molecule product; optionally, the method further comprises a step (iii): purifying the crude target mRNA molecule product obtained in step (ii) to obtain the target mRNA molecule.

[0164] The method for preparing the target cricRNA molecule in vitro of the present invention comprises the following steps:

[0165] (a) providing a double-stranded DNA template encoding a target circRNA molecule, wherein the double-stranded DNA template contains the repression module as described in the first aspect of the present invention; (b) using the double-stranded DNA template described in step (a) to perform an in vitro transcription reaction to obtain a precursor RNA (pre-mRNA) of the target circRNA molecule; (c) the precursor RNA (pre-mRNA) in step (b) is self-cleaved and cyclized to form a crude product of the target circRNA molecule; optionally, the method further comprises a step (d): purifying the crude product of the target circRNA molecule obtained in step (c) to obtain the target circRNA molecule.

[0166] The mRNA / circRNA prepared according to the method of the present invention can be used without further purification. Specifically, the mRNA / circRNA prepared according to the method of the present invention can be used in the absence of a step of removing the byproducts of the in vitro transcription reaction. In some embodiments, the mRNA / circRNA prepared according to the method of the present invention can be further purified. Various methods can be used to purify mRNA. For example, centrifugation, filtration and / or chromatography can be used to purify mRNA. In some embodiments, the synthesized mRNA is purified by LiCl precipitation or filtration or chromatography, or gel purification or any other suitable method. In some embodiments, mRNA is purified by HPLC. In some embodiments, mRNA is extracted in a standard phenol: chloroform: isoamyl alcohol solution well known to those skilled in the art. In some embodiments, mRNA is purified using tangential flow filtration. Suitable purification methods include those described in US2016 / 0040154, US2015 / 0376220, PCT Application No. PCT / US18 / 19978, filed on February 27, 2018, entitled “METHODS FOR PURIFICATION OF MESSENGER RNA,” and PCT Application No. PCT / US18 / 19954, filed on February 27, 2018, entitled “METHODS FOR PURIFICATION OF MESSENGER RNA,” U.S. Provisional Application No. 62 / 757,612, filed on November 8, 2018, and U.S. Provisional Application No. 62 / 891,781, filed on August 26, 2019, the entire contents of which are incorporated herein by reference and may be used to practice the present invention.

[0167] The mRNA molecules or circRNA molecules prepared using the above method can be used to prepare therapeutic drugs or preventive vaccines.

[0168] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods for the unrecorded specific conditions in the following examples are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are weight percentages and weight parts.

[0169] Example 1. Single-cycle IVT reaction to verify the hypothesis of antisense RNA formation

[0170] T7RNAP binds to double-stranded DNA containing a T7 promoter sequence and transcribes the template strand to form mRNA. When there is an overhang sequence at the 3' end of the linear DNA non-template strand, T7RNAP can bind to this 3' end overhang sequence, undergo non-T7 promoter-dependent transcription, and produce antisense RNA

[16] . Reference [6] reported an example of a 512B DNA template sequence (512 bp) with less secondary structure. The fully complementary 512B double-stranded DNA template transcribed the non-template strand in the IVT reaction to produce antisense RNA, but the mechanism of antisense RNA formation is still unclear. The inventors hypothesize that for a fully complementary linear double-stranded DNA template, when T7RNAP produces a run-off product, when the template strand dissociates from the non-template strand, the 3' end of the non-template strand is free and can bind to the free T7RNAP to undergo non-T7 promoter-dependent transcription, producing antisense RNA, which then pairs with the run-off transcript to form dsRNA. The following single-cycle IVT transcription reaction was designed to verify this hypothesis.

[0171] Single-cycle IVT transcription reaction using Figure 3 The linear DNA template (SEQ ID NO: 62-69) in the experiment is used. The 3' end of the DNA template chain has an extended sequence and a biotin label. The non-template chain and the template chain are annealed and paired. The double-stranded DNA can be coupled to the SA magnetic beads through the biotin label at the 3' end of the template chain. The experimental process is shown in Table 1. First, the SA magnetic beads are coupled to the biotin-labeled DNA template, and mixA containing T7RNAP, ATP, and GTP is added. Then, the DNA template chain is transcribed to the AA mismatch base position and cannot continue due to the absence of UTP. At this time, the excess T7RNAP, ATP, and GTP in the reaction system are removed, and mix B containing UTP and ATP is added. The T7RNAP bound to the template chain can continue to be transcribed. When it reaches the 3' end, since the template is two bases GG and there is no CTP in the system, mRNA transcription stops again. This time, the excess UTP and ATP are removed, and mix C containing T7RNAP, fluorescently labeled UTP (Alexa647-UTP) and GTP is added. If the non-template DNA chain can undergo non-T7 promoter-dependent transcription, the transcribed antisense RNA contains fluorescently labeled UTP.

[0172] Table 1. Single-cycle IVT transcription reaction system and experimental process

[0173]

[0174]

[0175] Single cycle IVT transcription reaction system (10X IVT reaction buffer I: 400mM Tris-HCl pH7.9, 600mM MgCl2, 20mM Spermidine, 100mM DTT), the experimental process is described in Table 1.

[0176] exist Figure 3 In the schematic diagram, A40 (SEQ ID NO: 62 and 63) is used as a template. When T7RNAP transcribes to the last two bases of the DNA template chain, since CTP is not added to the reaction system, T7RNAP stagnates here. At this time, the non-template DNA chain and the template chain have been sufficiently separated. The 3' end of the non-template chain is free and can be transcribed by T7RNAP independently of the T7 promoter to generate antisense RNA. The antisense RNA can pair with mRNA to form dsRNA. The reaction product is sampled and mixed with an equal volume (2X) of urea gel loading buffer (90% formamide, 50mM EDTA, 0.05% bromophenol blue, 0.05% xylenol), heated at 65-70°C for 3 minutes, and electrophoresed. The 15% polyacrylamide urea gel was prepared using the UreaGel system (National Diagnostics). The EPS600 electrophoresis instrument has a rated power of 10w and an electrophoresis time of 1.5 hours. Fluorescence photography was performed using an iBright1500 imager. Figure 4 Lane 4 shows that the A40 DNA template forms antisense RNA, indicating that the single-cycle IVT transcription reaction captures the formation of antisense RNA independent of T7 promoter transcription.

[0177] Figure 3 In the schematic diagram, the single-cycle IVT transcription reaction uses A38, A35, and A31 (SEQ ID NOs: 64-69) as templates. When T7RNAP transcribes to the 3' end of mRNA and stalls due to the absence of CTP in the reaction system, the template chain and the non-template DNA chain are not fully opened. Compared with A40 (2 walk to go, i.e., 2 bases away from complete transcription of the template), A38, A35, and A31 are 4, 7, and 11 bases away from complete transcription of the template, respectively. The template chain and the non-template chain are not fully dissociated, and the non-template DNA chain does not have a free 3' end, so T7RNAP cannot synthesize antisense RNA. Figure 4Lanes 1, 2, and 3 in Figure 2 show that no antisense RNA was detected.

[0178] Generally, T7 RNAP recognizes the T7 promoter sequence, binds to the linear DNA template, and catalyzes the synthesis of mRNA in the 5' to 3' direction; this example shows that when T7 RNAP is transcribed to the 3' end of the mRNA, since the 3' end of the non-template DNA chain is separated from the template DNA chain, the DNA non-template chain can bind to T7 RNAP and undergo transcription independent of the T7 promoter to form antisense RNA.

[0179] Example 2. Study on the formation mechanism of 3'-end extension byproducts in IVT reaction

[0180] Another byproduct in the IVT reaction is the 3' extension byproduct. In order to investigate whether there is a difference in the 3' extension transcription pattern produced by T7 RNAP between the released RNA (without promoter) and the RNA transcribed from the DNA template containing the T7 promoter, the 3' extension of both in the IVT reaction was detected and analyzed.

[0181] The 3'-end extension process of 24mer synthetic RNA and its corresponding 24-base runoff transcript was detected: 24mer synthetic RNA (SEQ ID NO: 1) and the linear DNA template (SEQ ID NO: 93, 94) for transcription of the RNA were used for IVT reaction, and samples were taken for electrophoresis at different time points. The results are as follows: Figure 5 As shown in the electrophoresis diagram, as the reaction time goes by, the 3' end of the 24mer synthetic RNA is continuously extended, the electrophoresis band gradually moves upward, and the RNA molecular weight gradually increases ( Figure 5 , right arrow); however, the promoter-driven transcript was observed to be separated into two different bands in the electrophoresis gel after only 1 min of reaction ( Figure 5 , left arrow), namely the runoff transcript at the bottom and the 3'-end extension byproduct with a larger molecular weight at the top; and, as the reaction time goes by, the amount of these two groups of RNA products increases, but no gradual increase in the molecular weight of the 3'-end extension byproduct is observed.

[0182] This result suggests that there are additional RNA 3'-end extension mechanisms that can be used to extend promoter-driven transcripts to form 3'-end extension byproducts, and the mechanism of formation of such byproducts is different from the mechanism by which the released transcribed RNA pairs with itself and then extends to form 3'-end extension byproducts.

[0183] The above findings prompted the inventors to consider whether T7 RNAP is released from the end of the linear template DNA in time at the end of transcription. To this end, the inventors designed a simplified linear DNA template containing a poly(A) sequence downstream of the T7 promoter for IVT reaction to verify the above hypothesis:

[0184] Specifically, two single-stranded DNAs, T7-PolyA-F (SEQ ID NO: 70) and T7-PolyA-R (SEQ ID NO: 71), are annealed and paired to form a dsDNA template containing a T7 promoter sequence, and RNA is transcribed from the template. In theory, an RNA product of a specific length should be generated, because the transcribed 26mer RNA contains a poly (A) tail and cannot be cis-complementarily paired to produce a 3' extension (double-stranded DNA template and 26mer theoretical RNA product, such as Figure 6 (in sequence annotation).

[0185] The IVT reaction was carried out using the system in Table 2. NTPmix of different components were added to the reaction system in Table 2 (10X IVT reaction buffer I as described above), and the reaction was carried out at 37°C for 2 hours. The reaction product was sampled and subjected to 15% urea gel electrophoresis. The urea gel was stained with methylene blue staining solution (0.2% Methylene blue, 0.4M NaAc, pH 4.7) for 10 minutes, decolorized with deionized water for 1-2 hours until the background was transparent, and photographed with a Biorad gel photographer.

[0186] Table 2. IVT transcription reaction system (20ul)

[0187]

[0188]

[0189] Add 4ul NTP mix to the IVT reaction system according to the ratio in the table below.

[0190] / - + G GA GC GU GTP (100 mM) 0ul 1ul 1ul 1ul 1ul 1ul ATP(100mM) 0ul 1ul 0ul 1ul 0ul 0ul CTP (100 mM) 0ul 1ul 0ul 0ul 1ul 0ul UTP(100mM) 0ul 1ul 0ul 0ul 0ul 1ul RNase-free ddH2O 4ul 0ul 3ul 2ul 2ul 2ul

[0191] The results are as follows Figure 6 As shown: Lane 1 is a chemically synthesized 26mer poly(A) RNA, with a single band on the gel image. Lane 2 is an IVT reaction system without NTP, with no RNA transcription product. Lanes 4, 6, and 7 are reaction systems with only G, GC, or GU added, and no RNA transcription product was produced. In lane 3, four nucleotides were added to the reaction system, and an abnormal 3'-end extension byproduct with a length exceeding the expected length was observed; in lane 5, only two nucleotides, GA, were added to the reaction, excluding the production of antisense RNA and excluding the extension with RNA itself as a template, and an abnormal 3'-end extension byproduct with a length exceeding the expected length was also observed.

[0192] However, when the IVT reaction was performed using synthetic poly(A) or poly(U) RNA sequences (SEQ ID NO: 72, 95) in the presence of T7RNAP, the IVT reaction did not produce any 3'-end extension byproducts because poly(A) RNA or poly(U) RNA could not fold back to complement each other or complement each other between two RNA molecules. Figure 7 ).

[0193] These experimental results indicate that the DNA template chain itself can be transcribed to produce a large number of 3'-end extension byproducts in the IVT reaction, demonstrating a unique mechanism for the formation of 3'-end extension byproducts: that is, T7RNAP fails to fall off from the end of the DNA template chain in time, and when T7 RNAP, DNA template chain and transcription RNA coexist (transcription bubble exists), the T7RNAP transcription reaction is not terminated in time and a 3'-extension byproduct (transcriptional slippage) is produced (or it can be called: Co-transcriptional 3'extension).

[0194] Example 3. Single-subunit and multi-subunit RNA polymerases can form 3'-end extension products using mRNA itself as a template

[0195] mRNA-T2 (Note 1, SEQ ID NO: 1) is the same sequence as the synthetic 24mer RNA in the literature [5], in which the underlined bases can cis-complementarily pair to form a hairpin. Under the catalytic action of T7RNAP, this sequence can react with its own RNA as a template to form a 3'-end extension product (which can be called: Post-transcriptional 3'extension).

[0196] This example aims to investigate whether multi-subunit E. coli RNAP and T. thermophilus RNAP can generate 3'-end extension products using RNA itself as a template, just like single-subunit T7 RNAP.

[0197] T7RNAP is a member of the single-subunit RNA polymerase family, other members of which include bacteriophage RNAP (T3, K11, SP6, N4) and mitochondrial RNAPs [17, 18]. T7RNAP is structurally similar to single-subunit nucleotide polymerases, such as Escherichia coli DNAP I and HIV-1 reverse transcriptase. Single-subunit RNAP recognizes promoter sequences and does not require auxiliary regulatory factors, which is fundamentally different from multi-subunit RNAP. Multi-subunit RNAPs of different species evolved from the same ancestor. The core enzyme of E. coli RNAP consists of five subunits (β′βα2ω), and almost all species have DNA-dependent RNA polymerases that are related to the evolution of β′, β, α, and ω subunits [19, 20]. T. thermophilus RNAP is also a multi-subunit bacterial RNAP that is heat-resistant. T7RNAP, E. coli RNAP, and T. thermophilus RNAP wild-type (WT) RNA polymerase were prepared using reference methods [21, 22, 23].

[0198] mRNA-T2 and three RNA polymerases were reacted in the reaction system of Table 3 at 37°C and 50°C for 2 hours respectively. The reaction products were sampled and subjected to 15% urea gel electrophoresis. The electrophoresis and electrophoresis gel operations were the same as those in Example 2.

[0199] Table 3. 3' extension reaction system of single-stranded RNA catalyzed by RNA polymerase (20ul)

[0200] 10x IVT reaction buffer I 2μl <![CDATA[H2O(RNase free)]]> 4μl NTPs mix (100mM each) 4μl RNase inhibitor (40U / μl) 1μl RNA polymerase (1 mg / μl) 2μl Single-stranded RNA (20uM) 7μl

[0201] The results are as follows Figure 8 As shown, lane 1 is a negative control, and RNAP is not added to the reaction system. Lanes 2, 3, and 4 show that under the reaction conditions of 37°C, the three RNA polymerases all use mRNA-T2 itself as a template to form 3'-end extension products. Under the reaction conditions of 50°C, lane 3' shows that E. coli RNAP is inactivated and there is no 3' extension product. Lanes 2' and 4' show that T7RNAP and T. thermophilusRNAP produce 3'-end extension products.

[0202] This example shows that both single-subunit and multi-subunit RNA polymerases produce 3'-end extension products using mRNA as a template.

[0203] Based on the exploration of the formation mechanism of antisense RNA and 3'-end extension byproducts in the IVT reaction in the above Examples 1-3, the inventors believe that in order to suppress the formation of IVT byproducts from the root, optimization or intervention is required at three key points: first, when the transcription reaction is about to end, the 3' end of the DNA non-template chain is freed, and the sequence at this end needs to be protected or shrunk so that it cannot bind to T7RNAP to initiate antisense RNA synthesis; second, the DNA template chain and T7RNAP should be quickly dissociated after the transcription is completed to terminate the transcription reaction and avoid the occurrence of transcriptional sl ippage; third: the 3' end of the RNA generated by transcription needs to be protected to suppress the self-complementary pairing of mRNA and the binding of T7RNAP to produce 3'-end extension byproducts.

[0204] Therefore, the inventors envisioned designing and introducing a specially designed hairpin structure sequence into the linear DNA template to play a role similar to transcription termination, so that the DNA template and T7RNAP dissociate in time, and at the same time, the hairpin sequence also plays a role in inhibiting the binding of RNA and T7RNAP to produce 3'-end extension byproducts in the transcribed mRNA. Therefore, the design elements of the hairpin sequence and its effect of inhibiting the formation of byproducts are further explored in subsequent examples.

[0205] Example 4. When the 3' end of mRNA forms a hairpin structure, adding an unpaired base to the 3' end of the hairpin can inhibit the formation of the 3' end extension product

[0206] As shown in Note 1, the hairpin sequences of mRNA-T2.1, mRNA-T2.2, and mRNA-T2.3 (SEQ ID NO: 2, 3, and 4) evolved from mRNA-T2. The underlined bases at the 3' end can be complementary to form a hairpin, and there is no unpaired base at the 3' end. The M512-HP sequence (SEQ ID NO: 5) has 4 A's at the 3' end of the hairpin structure, and the A at the end of the hairpin may still pair with the U on the RNA itself. The 3' end extension reaction system is shown in Table 3. The reaction was carried out at 37°C for 2 hours, and samples were taken for 15% polyacrylamide urea gel electrophoresis.

[0207] The results are as follows Fig. 9 As shown: Due to the 3' end of mRNA-T2.1 folding back, the terminal base can complement each other, so the three RNA polymerases all produce 3' extension byproducts ( Fig. 9 The 3' end of mRNA-T2.2, mRNA-T2.3, and m512-HP are folded back, and the terminal bases can also be complementary. The difference is that the hairpin necks in these three RNAs are relatively long, with 7 bases or longer. The results show that T7RNAP does not produce 3' extension byproducts ( Fig. 9Lane 2 of Figures B, C, and D), while E. col i RNAP and T. thermophilus RNAP can both produce 3' extension byproducts ( Fig. 9 Lanes 3-4 of B, C, and D in the Figure 1); This indicates that due to the limitation of the T7RNAP structure, the RNA complementary sequence of the 7-base hairpin neck cannot be accommodated, so T7RNAP cannot bind to RNA to produce 3' extension. In the polyA-HP sequence (SEQ ID NO: 6), the RNA hairpin neck has 5 bases, and there are 5 bases A at the 3' end that cannot be complementary. None of the three RNA polymerases produced 3' extension byproducts ( Fig. 9 (Fig. E).

[0208] This example shows that when the 3'-end bases of mRNA form a hairpin structure, adding an unpaired base to the 3'-end of the hairpin structure can inhibit the formation of the 3'-end extension product.

[0209] Example 5. Effect of the number of unpaired bases connected by the hairpin structure on the 3'-end extension product in the RNA poly(A) sequence

[0210] In Note 1, the hairpin structure in the RNA Poly(A) sequence of Poly(A)-HP0, Poly(A)-HP1, Poly(A)-HP2, Poly(A)-HP3, Poly(A)-HP4, Poly(A)-HP (i.e., Poly(A)-HP5) (sequences are shown in SEQ ID NOs:6-11, respectively) contains 5 paired bases, and 0-5 A's are connected to the 3' end, respectively. They reacted with three RNA polymerases, and the 3' end extension reaction system was shown in Table 3. The reaction was carried out at 37°C for 2 hours, and samples were taken for 15% polyacrylamide urea gel electrophoresis.

[0211] Fig.10 A in the figure shows that a small amount of 3'-end extension products were observed when T7RNAP used Poly(A)-HP0 as template. Fig.10 Lanes B and C in lane 2 show that E. coli RNAP and T. thermophilus RNAP clearly produced 3'-end extension products using Poly(A)-HP0 as a template. Since the 3' end of the hairpin structure of Poly(A)-HP0 has no unpaired bases, a 3'-end extension product was produced. However, the 3' ends of the hairpin structures of Poly(A)-HP1, Poly(A)-HP2, Poly(A)-HP3, Poly(A)-HP4, and Poly(A)-HP5 contained 1-5 unpaired bases, and no 3'-end extension products were produced.

[0212] This example shows that the 3' end of the hairpin structure of the poly(A) sequence connected to at least one base A, that is, at least one unpaired base, can effectively inhibit the generation of 3' end extension byproducts using mRNA as a template.

[0213] Example 6. Effect of the stem length of the hairpin structure on the 3'-end extension product in the poly(A) sequence of mRNA

[0214] In Note 1, the RNA sequences of the RNA-HP-stem series contain 3, 4, 5, 6, 7, 8, and 9 base hairpin necks (stem) (SEQ ID NO: 12-18), respectively. The underlined hairpin neck paired bases, and there is no unpaired base at the 3' end, corresponding to Fig.11 Lanes 1-7 of the gel image shown. RNA-HP-stem series RNA reacted with three RNA polymerases, namely Fig.11 The reaction systems of A, B, and C are shown in Table 3. The reaction was carried out at 37°C for 2 hours, and samples were taken for 15% polyacrylamide urea gel electrophoresis. + represents the addition of RNA polymerase to the reaction system; - represents the control without RNA polymerase.

[0215] Fig.11 In middle A, compared with lanes 3(-) and 4(-), lanes 3(+) and 4(+) (the hairpin structure of their templates contains 5 and 6 paired bases, respectively) show that the 3'-end extension product produced by T7RNAP is significantly reduced; further increasing the length of the hairpin neck, no 3'-end extension product was observed. Fig.11 B and C show that as the length of the hairpin neck increases, the 3'-end extension product in the E. coli RNAP and T. thermophilus RNAP reaction systems tends to decrease. In lane 7 (+), no 3'-end extension product is observed for the hairpin neck RNA containing 9 bases.

[0216] The crystal structure literature related to the T7RNAP transcription extension complex

[24] shows that RNA-DNA forms a 7-bp base complementary pairing fragment, forms a complex with T7RNAP (i.e., transcription bubble), and transcribes and extends in the channel formed by the RNA polymerase structure. The 5' end of the mRNA exits to the exit, and the 3' end forms a new base pairing with the template, and the synthesis and extension are continuously carried out. This process is similar to the primer binding to the DNA template and extension under the catalysis of DNA polymerase. In this embodiment, the mRNA cis forms a hairpin complementary pairing, the hairpin loop has 4 bases, and the template and extension are the same RNA chain, that is, the template chain and the extension chain are connected and cannot dissociate and exit, and the extension length is limited. Fig.11A shows that when the hairpin neck length of T7RNAP and RNA is 5-6 bases, no 3'-end extension is observed, and when the hairpin neck length of E. coli RNAP, T. thermophilus RNAP and RNA is 9 bases, no 3'-end extension is observed in B and C. This experimental result can be explained by the structural analysis of the transcription bubble.

[0217] Example 7. Effect of the hairpin loop of the hairpin structure on the 3'-end extension product in the poly(A) sequence of RNA

[0218] In Note 1, the RNA sequences of the RNA-HP-loop series contain 2, 3, 4, 7, 10, 13, and 16 base hairpin loops (SEQ ID NOs: 19-25), respectively. The three underlined bases are the hairpin necks, and there are no unpaired bases at the 3' end (e.g. Fig.12 The RNA-HP-loop series RNAs were reacted with three RNA polymerases, respectively, and the 3'-end extension reaction system was shown in Table 3. The reaction was carried out at 37°C for 2 hours, and samples were taken for 15% polyacrylamide urea gel electrophoresis.

[0219] Fig.12 The results show that hairpin loops of different lengths, ranging from 2 to 16 bases, all reacted to generate 3'-end extension products under the catalysis of the three RNAPs. Hairpin loops of different lengths failed to suppress 3'-end extension byproducts.

[0220] Example 8. In the poly(A) sequence of mRNA, the 3' end hairpin structure enhances mRNA stability and resists Exonuclease T enzymatic degradation

[0221] As shown in Note 1, A5-HP (SEQ ID NO: 26) contains a hairpin structure, and the poly (A) sequence of AC-N (SEQ ID NO: 27) does not have a hairpin structure. They were dissolved to 20uM in DEPC water and then mixed with an equal volume of Exo T reaction buffer (50mM PotassiumAcetate, 20mM Tris-acetate, 10mM Magnesium Acetate, 1mM DTT, pH 7.9) to a final concentration of 10μM. Exo T was gradiently diluted with Exo T reaction buffer, with 0.5U / μl as the starting maximum concentration and the enzyme amount decreasing by 3 times. 11μl RNA (10uM) was mixed with 4μl Exo T of different concentration gradients and incubated at 25°C for 3h. Among them, Exo-T has RNA cleavage activity in the 3' to 5' direction. The reaction product was sampled for electrophoresis and 15% polyacrylamide urea gel electrophoresis, and the operation was the same as Example 2.

[0222] The results are as follows Fig.13As shown, in lane 1, ExoT was not added to A5-HP1, and there was no enzymatic digestion. Lanes 2, 3, 4, and 5 showed that as the amount of ExoT increased, Exo-T digested the 5 A adenine bases at the 3' end of the hairpin structure HP1 in the A5-HP1 single-stranded RNA. Lane 6 showed that the hairpin structure of HP1 prevented ExoT from continuing to digest. For the AC-N single-stranded RNA corresponding to poly(A) without a hairpin module, lane 1' did not add ExoT and there was no enzymatic digestion. Compared with lane 1', lane 2' observed that the single-stranded RNA was digested under the action of low concentration ExoT. As the amount of Exo T enzyme in the reaction system increased, the RNA in lanes 3', 4', 5', and 6' was significantly degraded.

[0223] This example shows that when the poly (A) tail of mRNA contains a hairpin structure, it can resist ExoT enzymatic degradation and has better stability; while the poly (A) without a hairpin structure is degraded by ExoT. The poly (A) tail of mRNA contains a hairpin structure, which makes it more stable.

[0224] Example 9. Effect of the number of unpaired bases in the hairpin structure on transcription byproducts in IVT reaction using a linear DNA template containing poly(A)

[0225] The IVT reaction uses a linear DNA template containing a T7 promoter and T7 RNAP to transcribe a short RNA chain of a specific sequence. The transcription products can be distinguished on the electrophoresis gel as RNA products that initiate transcription from +1 to +6 bases after the T7 promoter (run-off products), and premature termination fragments (abortive transcriptions) can also be observed

[25] .

[0226] The DNA template in Note 2 contains a T7 promoter sequence (italics), a hairpin structure in the poly(A) sequence (5 bases in the stem sequence, indicated by underscores), and the 3' ends of the hairpin structures of T7-HP-A0 to T7-HP-A8 (SEQ ID NO: 28-36) are connected to 0-8 A, respectively, i.e., the number of unpaired bases is 0-8. T7-HP-AC does not contain a hairpin structure. The IVT reaction components are listed in Table 4, react at 37°C for 2 hours, and sample for 15% polyacrylamide urea gel electrophoresis.

[0227] Table 4. IVT transcription reaction system (50 μl)

[0228] 10x IVT reaction bufferI 5ul NTP mix (25mM each) 10ul RNAse inhibitor (40U / μL) 1ul T7 RNAP (1 mg / mL) 5ul Linearized dsDNA template 1ug RNase-free ddH2O Up to 50ul

[0229] The results are as follows Fig.14As shown, lane 10 shows the T7-HP-AC template without a hairpin structure. The IVT reaction produces 3' extension (transcriptional slippage), aggregation (aggregates) and premature termination fragments (abortive transcriptions), and normal transcription products (run-off products) are not seen. Lanes 1-9 correspond to templates containing hairpin structures and 0-8 unpaired bases. Lanes 5-7, templates with 4-6 unpaired bases at the 3' end of the hairpin, IVT reactions produce fewer 3' extension and aggregation byproducts, and the transcription products (run-off products) of the G bases at the +1 and +2 positions after the T7 promoter are clearly visible.

[0230] It can be seen that in this embodiment, the T7-HP-A0 sequence in lane 1 contains a hairpin structure, but there is no unpaired base at the 3' end of the hairpin, and transcriptional byproducts such as 3' extension can also be observed; the T7-HP-AC template sequence does not contain a hairpin structure and has no cis-base complementary pairing, but a large number of byproducts are produced, and normal transcription products are basically not observed on the gel map. The mechanism for the generation of the above 3' extension byproducts is mainly that T7RNAP fails to dissociate from the DNA template chain in time, transcription fails to terminate effectively, and transcriptional slippage occurs.

[0231] This example shows that when the number of unpaired bases at the 3' end of the hairpin structure in the linear DNA template is set to 4-6, byproducts such as 3' extension and aggregation in the IVT reaction are significantly reduced.

[0232] Example 10. The linear DNA template poly (A) sequence contains a hairpin structure and a 3' unpaired base. The effect of the hairpin stem length on the stability of the IVT product

[0233] Fig.15 The 8 groups of linear DNA templates (SEQ ID NO:73-84) contain T7 promoters, and the poly (A) sequence contains a hairpin structure, and the 3' end of each is connected to 5 unpaired bases. The hairpin loops are all four bases (bold, marked with dots), and the number of bases in the hairpin neck (indicated by the dotted line above the sequence) is 1-8, that is, the length of the Stem is different. The IVT reaction components are shown in Table 4, and the reaction is carried out at 37°C for 2h. After the reaction is completed, 1μL DNAse I (40U / μL) is added to degrade the DNA template, and the IVT product is purified using an RNA purification kit (NEB).

[0234] Take 2.5 μg RNA product, add 2.5U Exo T RNA exonuclease to the sample group (+), Exo-T has RNA cleavage activity from 3' to 5' direction, and test the anti-enzymatic stability of RNA product. The control group (-) does not add Exo T. Incubate at 25℃ for 2h, and take samples for 15% polyacrylamide urea gel electrophoresis analysis.

[0235] The results are as follows Fig.16 As shown, the template hairpin in lane 1 has only one base pairing, and the RNA product bands in lane 1 (-) can be observed to be uneven. Compared with 1 (-), the RNA product in 1 (+) is digested by Exo T, that is, Exo T digests the 5 unpaired bases at the 3' end, and further digests the hairpin paired bases and its 5' end sequence. The template hairpin in lane 2 has two base pairs. Compared with 2 (-), the RNA product in 2 (+) is partially digested by Exo T, that is, the 3' end is partially digested, but there is no obvious further digestion. Lanes 3-8 show that mRNA with a hairpin neck (Stem) length of 3 base pairs or more can resist RNA digestion from 3' to 5' by Exo-T. After Exo T cuts off the 5 unpaired bases at the 3' end, the hairpin structure blocks further digestion.

[0236] This example shows that the introduction of a hairpin structure into a linear DNA template and the unpaired bases at both ends thereof, and the IVT transcription product RNA also containing a hairpin structure, can improve the stability of RNA.

[0237] Example 11. A linear DNA template containing a repression module transcribes polyA sequences of different lengths to obtain transcription products of defined lengths

[0238] In Example 1, a single-cycle IVT reaction was used to demonstrate how a double-stranded DNA template produces antisense RNA. The experiment showed that when mRNA is transcribed to the 3' end, the DNA template strand and the non-template strand are dissociated, and the 3' end of the non-template strand is free and can bind to the free T7 RNAP in the reaction system, and transcription independent of the T7 promoter occurs to produce antisense RNA. Antisense RNA pairs with mRNA to form dsRNA byproducts.

[0239] Example 2 designed a simplified linear DNA template, and selectively added a specific nucleotide substrate to the IVT reaction system, which can exclude the production of antisense RNA and RNA self-pairing byproducts, so that the production of 3' extension byproducts is only related to the transcription of the DNA template chain. Thus, a unique 3' extension byproduct formation mechanism was discovered, that is, T7RNAP failed to fall off from the end of the DNA template chain in time, the transcription bubble did not dissociate in time, and a 3' extension transcription product (transcriptional slippage) with a length exceeding the expected length was produced.

[0240] Examples 3, 4, and 5 show that when the 3'-end bases of mRNA form a complementary paired hairpin structure in cis, the single-subunit T7 RNAP and the multi-subunit Ecoli RNAP and T. thermophilus RNAP can all generate 3'-end extension using the mRNA itself as a template. However, when there are unpaired bases at the 3'-end of the hairpin, especially at the 3'-end, no 3'-end extension occurs or the 3'-end extension is significantly reduced.

[0241] Examples 6 and 7 respectively explored the effects of the RNA 3' end hairpin neck length and hairpin loop length on RNA 3' extension byproducts.

[0242] Example 8 shows that the hairpin structure at the 3' end of RNA can resist the enzymatic degradation of Exo T RNA exonuclease and enhance the stability of RNA.

[0243] Example 9 shows that the polyA tail of the linear DNA template contains a hairpin structure and unpaired bases, which can significantly reduce the byproducts of the IVT reaction.

[0244] Example 10 shows that the introduction of a hairpin structure into the polyA tail of a linear DNA template and the unpaired bases at both ends, and the IVT transcription product RNA also containing a hairpin structure, can improve the stability of the RNA.

[0245] Based on the results of the above embodiments, the hairpin structure and the base sequence design at both ends of the hairpin structure are defined as a repression module. The repression module can be added downstream of the linear double-stranded DNA template, or it can be added to the poly (A) tail sequence of the linear double-stranded DNA template. The unpaired base at the 3' end of the repression module is designed according to the DNA template sequence. When the repression module is added to the poly (A) sequence, the unpaired base at the 3' end of the repression module is adenine base A.

[0246] The 47, 55, 65, and 75mer linear DNA template sequences used in this example are shown in Note 2 (SEQ ID NOs: 38-42), which can be used to transcribe and produce poly(A) sequences of different lengths. The reaction system is shown in Table 4. The experimental operation is consistent with that in Example 9, i.e., the reaction is carried out at 37° C. for 2 hours, and samples are taken for 15% polyacrylamide urea gel electrophoresis.

[0247] Fig.17 Lanes 1, 3, 4, and 5 are the transcription products of template sequences SEQ ID NO: 38, 40, 41, and 42, all of which contain repression modules, and all of which yield IVT transcription products of a defined length. The template in lane 2 (SEQ ID NO: 39), whose poly (A) sequence does not contain a repression module, produces a large amount of byproducts in the IVT reaction, and no RNA product of a defined length is observed.

[0248] This example shows that the repression module can effectively suppress the production of IVT reaction byproducts.

[0249] Example 12. Effect of introducing a repressor module into the 512B series DNA template on the formation of dsRNA byproducts in the IVT reaction

[0250] In this embodiment, the suppression module is applied to Fig.18 In the IVT reaction of the 512B series templates (SEQ ID NO: 87-92, 96) shown in Table 4, the reaction system was as shown in Table 4. After reacting at 37°C for 2 hours, 1 μL of DNAse I (40 U / μL) was added to digest the template, and the product was purified using an RNA purification kit (NEB). The IVT product was quantified using a Nanodrop one spectrophotometer, and the dsRNA was detected using TBE gel and a dsRNA detection kit, respectively.

[0251] 500 ng of RNA sample was mixed with an equal volume (2X) of TBE loading buffer (89 mM Tris-Borate, 2 mM EDTA, pH 8.3, 65% glycerol, 0.05% bromophenol blue, 0.05% dimethylbenzene cyanol), heated at 65-70°C for 3 min, and subjected to 5% polyacrylamide TBE gel electrophoresis (Table 5.5% TBE gel composition), 180 V, 35 min, then stained with 25 ug / ml acridine orange (Acridine orange, AO. Sigma) staining solution for 10 min, decolorized with deionized water for 10 min, and the gel was placed on the iBright 1500 instrument for photographic analysis. Acridine orange is embedded in double-stranded nucleic acids, and green fluorescence can be detected at 530 nm. It electrostatically binds to the phosphate groups in single-stranded nucleic acids, and red fluorescence can be detected at 640 nm.

[0252] RNA sampling was performed by semi-quantitative dsRNA Dot blot detection using the dsRNA Detector (RBP-HE101, Kactus Biosystems) kit. The experimental process is briefly described as follows: 2ul RNA sample was spotted on a positively charged nylon membrane (Roche). After the sample evaporated, the nylon membrane was placed in a 5% skim milk powder TBST solution (TBST, 10mM Tris.HCl, 15mM NaCl, 0.05% Tween20, pH7.5) and blocked at room temperature for 30 minutes. The fluorescently labeled dsRNA detector reagent was added to the above blocking solution to a final concentration of 4ug / ml and combined at room temperature for 30 minutes. The membrane was then washed three times with TBST buffer, each time for 3-5 minutes. The Dot blot fluorescence signal was detected by taking photos using the iBright 1500 imaging system.

[0253] Table 5. 5% TBE glue formula

[0254] 40%acry / bis 2.5mL 10x TBE 2mL ddH2O 15.5mL 30% APS 50μL TEMED 10μL

[0255] Table 6. Summary of 512B series DNA template sequence characteristics and IVT transcription product dsRNA detection results

[0256]

[0257] The results are as follows Fig.19 As shown in Figure 6, the TBE gel image in A and the dot blot test results in B are consistent. No dsRNA was detected in the IVT products of the linear DNA templates T7pro-512B1, T7pro-512B2, T7pro-512B-HP1, and T7pro-512B-HP2 containing the repression module. Table 6 summarizes the test results of the IVT products of the 512B series templates. According to the literature [6], the T7pro-512B template contains less secondary structure, and IVT transcription forms dsRNA byproducts. Both ends of the T7p-512B-T7p sequence contain T7 promoter sequences, and the IVT products are all dsRNA, which serves as a positive control for evaluating the dsRNA content.

[0258] The HPLC chromatography method of reference

[12] was used to separate mRNA and dsRNA in the IVT reaction product. In brief, a chromatographic column ( SEC-1000, Sepax), the mobile phase was buffer A (0.1M TEAA, pH 7.0) and 38%–55% gradient buffer B (0.1M triethylammonium acetate [TEAA], pH 7.0, 25% [v / v] acetonitrile), the flow rate was 4 mL / min. Single-stranded mRNA was Fraction II, dsRNA was Fraction III, and RNA from different fractions was desalted and concentrated (30 kDa MWCO, Millipore) and verified by Dot blot. The results are shown in Fig.19 As shown in C, HPLC and dotblot analysis showed that the DNA template containing the repression module had a low dsRNA content in the IVT reaction product.

[0259] This example shows that the repression module is suitable for the 512B template sequence and can repress the formation of dsRNA byproducts of the IVT reaction.

[0260] Example 13. Detection of dsRNA byproducts by MDA5-ΔN ATPase hydrolysis reaction

[0261] MDA5 is an ATP-dependent helicase. MDA5-ΔN protein (N-terminal truncated protein) can bind to dsRNA in vitro, stimulate ATPase activity, hydrolyze ATP, and release phosphate groups. The released phosphate groups are detected by Malachite Green (MG) Phosphate Assay, that is, phosphate groups and ammonium molybdate form a phosphomolybdic acid complex under acidic conditions, and then form a color complex with malachite green. The light absorption intensity at a wavelength of 620nm is measured, which is proportional to the amount of phosphate groups. This is used to evaluate the content of dsRNA byproducts. The preparation of MDA5-ΔN protein and ATPase experiments were carried out according to the literature method [6].

[0262] In this embodiment, the MDA5-ΔN ATPase hydrolysis reaction was performed by premixing MDA5-ΔN (1.2uM) and IVT transcribed mRNA (5ng / ul) in a reaction buffer (20mM HEPES pH 7.5, 150mM NaCl, 1.5mM MgCl2and 2mM DTT), adding 2mM ATP to activate the reaction, reacting at 37°C for 15min, adding 100mM EDTA, and placing on ice to terminate the reaction. 5ul of the reaction solution was added to 195ul of MG Phosphate Assay working solution, and the light absorption at a wavelength of 620nm was measured with a multiskan microplate reader to detect the amount of byproduct dsRNA in the IVT product mRNA. The Malachite Green (MG) Phosphate Assay working solution was prepared by mixing MG stock solution (13 mM malachite green oxalate dissolved in 3.6 M sulfuric acid), 7.5% ammonium molybdate aqueous solution and 11% Tween 20 in a ratio of 1:0.25:0.02 (v:v:v), and then adding 4 times the volume of deionized water

[26] . The template sequence used in the IVT reaction is as follows Fig.18 shown.

[0263] The results are as follows Fig. 20 As shown, the T7p-512B-T7p template IVT product (column 3) has the strongest A620 signal in the MDA5-ΔN ATPase reaction, followed by 512B (column 2), that is, the amount of dsRNA by-products is relatively high; T7p-512B-HP1 and T7p-512B-HP2 containing a hairpin structure and unpaired bases at the 3' end have the weakest A620 signals, that is, the amount of dsRNA by-products is the least.

[0264] Example 14. Dual fluorescein reporter gene assay driven by interferon (IFNβ) in HEK293T cells to detect dsDNA

[0265] When the MAD5 receptor expressed by the cell binds to the byproduct dsRNA in the mRNA, it can activate the signaling pathway, produce IFN-β, and then drive the expression of the fluorescein reporter gene to produce a fluorescent signal. Based on this principle, this embodiment designed the following experiment to detect the formation of dsDNA byproducts.

[0266] HEK293T cells were cultured in 24-well plates (DMEM, 10% FBS, 1% penicillin / streptomycin) to a confluence of 95% and co-transfected with three plasmids using Lipo3000: MAD5 expression plasmid (pCDNA3.4-MAD5, 20 ng), IFN-β promoter-driven luciferase reporter gene plasmid (IFN-beta-pGL-3, 200 ng) and Renilla luciferase reporter gene plasmid (pRL-CMV, 10 ng). After 6 hours, the culture medium was replaced and polyI:C polyinosinic acid (positive control) and 512B series templates (sequences as shown in Figure 2) were transfected with Lipo3000. Fig.18 The RNA obtained by IVT reaction was shown in Figure 1. The RNA transfection amount was 1 μg. The experimental method was described in reference [6]. 20 hours after transfection, the cells were lysed to detect the fluorescence signal according to the interferon (IFNβ) driven dual fluorescein reporter gene operation manual (Promega).

[0267] like Fig.21 As shown, the fluorescence signal of the IVT products (columns 5 and 6) transfected with the template containing the repression module (SEQ ID NO: 92, 96) is equivalent to that of the negative control column 1 (no RNA transfection), that is, no dsRNA binding to the MAD5 receptor was detected, and there was no IFN-β-driven fluorescence reporter signal. Column 2 shows that the fluorescence reporter signal of polyinosinic acid (positive control) is the strongest, and the signals of columns 4 and 3 (template sequences are SEQ ID NO: 91, 88, respectively) decrease in turn, indicating that the IVT products of columns 4 and 3 contain dsRNA. The detection results of dsRNA in the cell experiment of this example are consistent with the results obtained by different test methods in Examples 12 and 13.

[0268] Example 15. IVT transcription of EGFP linear DNA template, the effect of the repressor module on dsRNA byproducts

[0269] In this example, the common gene EGFP was used as an IVT transcription template to explore the effect of the repression module on the dsRNA byproducts of the IVT transcription reaction. As shown in Note 3, the EGFP linear DNA sequence (SEQ ID NO: 43) contains a T7 promoter, a Kozac sequence, a 5'-UTR, an EGFP coding gene, and three different 3' end sequences [seq1], [poly(A)-IM], and [33poly(A)] (SEQ ID NO: 44, 45, 46). These three templates were used to perform IVT transcription reactions, and after the reaction products were purified and quantified, dsRNA was detected by TBE gel electrophoresis and Dot blot (dsRNA Detector kit). The specific experimental operations were the same as those in Example 12.

[0270] Fig. 22 5% TBE gel electrophoresis (A) and Dot blot (dsRNA Detector Kit) (B) consistently showed that the EGFP DNA template containing the repressor module [poly(A)-IM] had the lowest amount of dsRNA in the IVT reaction product (lane 2).

[0271] Example 16. Protein translation expression of IVT transcript mRNA containing repression module

[0272] In this example, the EGFP linear DNA template sequence (SEQ ID NO: 43) includes T7 promoter (italics), 5'UTR (black font), Kozac (italics), EGFP coding gene (black underline), and these segments are the same as the sequence in Example 15 (Note 3). The difference is that the sequences in the 3' box are [43Poly(A)], [53poly(A)], [43poly(A)-IM], [53poly(A)-IM] (SEQ ID NO: 47, 48, 49, 50). The poly(A) sequence of the DNA template containing the repression module [43poly(A)-IM], [53poly(A)-IM] and the poly(A) tail sequence [43Poly(A)], [53poly(A)] are compared, and the expression of EGFP protein after the two groups of IVT product mRNA are used for cell transfection. After the IVT product mRNA was purified and quantified, it was capped with vaccinia capping enzyme and mRNA Cap 2′-O-Methyltransferase (Kaixia Bio VCS-VE101, MEH-VE101) and then used for cell transfection. Expi293 cell density was 2.5E6cells / ml, and the viability was above 98%. In each well, 720μl was added, 2μg mRNA was mixed with 32μl opti-MEM and allowed to stand for 5min; 2μl Lipo3000 was mixed with 34μl opti-MEM and allowed to stand for 5min; the two were mixed and allowed to stand for 20min, and then the transfection complex was added dropwise to the cells and cultured at 37℃ overnight. The fluorescence signal of EGFP protein expression was detected by FACS.

[0273] Fig.23 The results showed that the mRNA containing the repression module [43Poly(A)-IM], [53Poly(A)-IM] had similar EGFP protein expression after cell transfection as the mRNA containing only poly(A) [43Poly(A)], [53Poly(A)], indicating that the repression module did not affect protein translation expression.

[0274] Example 17. Introducing a repressor module into the DNA template for preparing the precursor RNA to suppress the formation of dsRNA byproducts

[0275] Circular RNA (circRNA) can be produced by precursor RNA (pre-mRNA) through group I intron variable shearing. This example uses the template sequence for preparing circular RNA in the literature

[27] (Note 3, Seq-Full-length (SEQ ID NO: 55)). The intron and IRES sequences in the IVT transcription product contain many secondary structures, and the downstream template sequence is intercepted to explore the effect of the formation of dsRNA byproducts on RNA cyclization.

[0276] The repression module was then added downstream of the full-length sequence to examine the effect of the repression module on circRNA formation. When T7 promoter sequences [T7p] were added to both ends of the full-length sequence, dsRNA was artificially produced to observe whether circRNA was formed.

[0277] The circ-RNA-RBD template sequence was selected from the literature

[28] , which is also a group I intron variable shear template design. We also tried to add [IM] and [T7p] sequences downstream of the template to observe the formation of circRNA. The IVT reaction system is shown in Table 7, containing Pyrophosphatase (PYR-EE201, Kactus), (10x IVT reaction buffer II: 800mM HEPES–KOH, pH 7.5, 450mM MgCl2, 120mM Spermidine. 400mM DTT) and reacted at 37°C overnight. The preRNA was self-cleaved and circularized, and circRNA was also generated in the reaction system. The DNA template was digested with DNase I, and the RNA was purified by lithium chloride precipitation. The RNA product was dissolved in 200ul RNase-free water. Take 10ul RNA sample and add it to 40ul RNase-free ddH2O, then mix it with 50ul (2x urea gel loading buffer), heat at 65℃ for 3min, load the sample, and perform electrophoresis on 4% urea gel at 240V. Fig.24 Electrophoresis for B was 80 min, and electrophoresis for C was 40 min.

[0278] Table 7. IVT transcription reaction and pre-RNA self-cleavage circularization system

[0279] 10x IVT reaction buffer II 5ul NTP mix (25mM each) 10ul RNAse inhibitor (40U / μL) 1ul Pyrophosphatase (0.1U / ul) 1ul T7 RNAP (1 mg / mL) 5ul Linearized dsDNA template 1ug RNase-free ddH2O Up to 50ul

[0280] The results are as follows Fig.24As shown, A shows that three truncated sequences of different lengths downstream of the full-length sequence were selected as templates (Note 3 Seq-Truncate-1, 2, 3 (SEQ ID NO: 51-53)). In the absence of a repressor module, dsRNA was observed in IVT products 1', 2', and 3'. When the 3'-end box indicator sequence in these three sequences was replaced by the repressor module [IM] (SEQ ID NO: 54), B showed that no dsRNA was observed in lanes 1, 2, and 3. The yield of circRNA in lane 2 Seq-Full-length containing the repressor module in B was higher than that in lane 1 without the repressor module. Lane 3 shows that when both ends of Seq-Full-length contain T7 promoters (SEQ ID NO: 56), dsRNA is formed after RNA transcription, and no circularization products are observed. The DNA template used for circ-RNA-RBD in C comes from the literature

[28] , and the same group I intron variable shearing template design is used. The 3' end [TAACAGCATATCTAGTTT] sequence of the circ-RNA-RBD-Template in the literature

[28] was replaced by [IM] (SEQ ID NO: 54) and [T7p] (SEQ ID NO: 56), respectively. The yield of the template circRNA containing the repression module [IM] in lane 2 was higher than that of the template without the repression module in lane 1. Lane 3 showed that when both ends of the circ-RNA-RBD contained T7 promoters, dsRNA was formed after RNA transcription, and no circularization product was observed.

[0281] This example shows that the byproduct dsRNA produced by the IVT reaction cannot be cyclized, and the repressor module [IM] can repress the production of the byproduct dsRNA in the IVT reaction and promote the cyclization efficiency of the precursor RNA.

[0282] Summarize

[0283] First, the present invention explores the generation mechanism of IVT reaction byproducts through experimental design. Fig.25As shown in A: On the one hand, when the transcription reaction reaches the 5' end of the DNA template chain, the 3' end of the DNA non-template chain dissociates and can bind to the free T7 RNAP to undergo transcription independent of the T7 promoter, producing antisense RNA, which is complementary to the transcribed mRNA to form a long dsRNA byproduct; on the other hand, when the transcription reaction reaches the 5' end of the DNA template chain, if the transcription bubble does not dissociate in time and the transcription fails to terminate in time, the 3' end of the mRNA will continue to extend, producing a 3' extension byproduct (transcriptional slippage) that is longer than expected. Moreover, the mechanism by which transcriptional slippage produces 3' extension byproducts is different from the 3' extension mechanism produced by the cis-reentrant pairing of free mRNA. Fig.26 Figure A in the middle shows the transcription extension process of the IVT reaction: T7RNAP forms a complex (transcription bubble) with the DNA template and the transcribed mRNA, in which the DNA template and mRNA form a complementary sequence of a specific length. As the 3' end of the mRNA is synthesized and extended, the specificity loop structure of the T7RNAP at the other end separates the DNA template and the RNA complementary sequence, allowing the 3' end of the DNA template and the 5' end of the mRNA to exit the transcription bubble from their respective exits. As for the cis-complementary 3' extension mechanism of mRNA itself, Fig.26 As shown in B: When RNA self-primes and complexes with T7RNAP, it can extend at the shorter 3' end of the complementary sequence. However, T7RNAP has a limited capacity for the length of the RNA complementary sequence. As the 3' end of the RNA is extended, the other end cannot be separated and exit the transcription bubble.

[0284] According to the above mechanism, the present invention designs a repression module to suppress the production of antisense RNA and 3' extension byproducts in the IVT reaction. The mechanism of action of the repression module is as follows Fig.25 As shown in B: On the one hand, when the transcription reaction reaches the 5' end of the DNA template chain, the 3' end of the DNA non-template chain dissociates. Since the 3' end of the DNA non-template chain contains the repression module of the present invention, it cannot bind to the free T7 RNAP, thereby inhibiting the production of antisense RNA; on the other hand, when the transcription reaction reaches the 5' end of the DNA template chain, the repression module of the present invention produces a similar transcription termination effect, dissociates the transcription bubble, terminates transcription in time, inhibits the production of the 3' extension byproduct transcriptional slippage, and obtains the expected length and high uniformity of mRNA. In addition, the 3' end of the mRNA produced by transcription of the DNA template containing the repression module of the present invention also contains the corresponding repression module sequence, thereby inhibiting the production of the cis-complementary 3' extension byproduct of the mRNA itself.

[0285] Note 1: Chemically synthesized single-stranded RNA sequence, the underline indicates the hairpin neck (Stem) sequence

[0286]

[0287] Note 2: DNA template sequence (5'-3')

[0288]

[0289]

[0290] Note 3: DNA sequence

[0291] Example 15, Example 16

[0292] T7 promoter+5'UTR+Kozsc+ EGFP + [seq1] (SEQ ID NO: 43)

[0293]

[0294] The following sequence can replace the sequence [seq1] in the box

[0295] [seq1](SEQ ID NO:44)

[0296] GTCGACGGATCCGATCTGGTACTGCATGCACGC

[0297] [polyA-IM] (SEQ ID NO: 45)

[0298] AAAAAAAAAAAAA CCCGC TTCG GCGGG AAAAAA

[0299] [33polyA] (SEQ ID NO: 46)

[0300] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA

[0301] [43polyA] (SEQ ID NO: 47)

[0302] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA

[0303] [53polyA] (SEQ ID NO: 48)

[0304] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA

[0305] [43polyA-IM] (SEQ ID NO: 49)

[0306] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CCCGC TTCG GCGGG AAAAAA

[0307] [53polyA-IM] (SEQ ID NO: 50)

[0308] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CCCGC TTCG GCGGG AAAAAA

[0309] Embodiment 17

[0310] Seq-Truncate-1 (SEQ ID NO: 51)

[0311]

[0312] Seq-Truncate-2 (SEQ ID NO: 52)

[0313]

[0314] Seq-Truncate-3 (SEQ ID NO: 53)

[0315]

[0316] [IM] can replace the sequences in the above Seq-Truncate-1,2,3 boxes

[0317] [IM] (SEQ ID NO: 54)

[0318] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CCCGC TTCG GCGGG AAAAA

[0319] Seq-Full-length (SEQ ID NO: 55)

[0320]

[0321]

[0322] [IM](SEQ ID NO:54)

[0323] AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CCCGC TTCG GCGGG AAAAA

[0324] [T7p](SEQ ID NO:56)

[0325] TAACAGCATATCTAGCCTATAGTGAGTCGTATTA

[0326] References

[0327] 1.The clinical progress of mRNA vaccines and immunotherapies.Nature Biotechnology.40,840–854(2022)

[0328] 2.Circular RNAs:analysis,expression and potential functions.Development 143,1838-1847(2016).

[0329] 3.The highly efficient T7 RNA polymerase:A wonder macromolecule in biological realm.Int J Biol Macromol.18(Pt A),49-56(2018)

[0330] 4.A specific,promoter-independent activity of T7 RNA polymerase suggests a general model for DNA / RNA editing in single subunit RNA polymerases.Scientific Reports,8,1-13(2018)

[0331] 5.3'end additions by T7 RNA polymerase are RNA self-templated,distributive and diverse in character-RNA-Seq analyses.Nucleic Acids Res.46(18),9253-9263(2018).

[0332] 6.An origin of the immunogenicity of in vitro transcribed RNA.NucleicAcids Research,46(10),5239–5249(2018)

[0333] 7.Payload distribution and capacity of mRNA lipidnanoparticles.Nature Communications,13(5561)1-13(2022)

[0334] 8.Immunogenicity of In Vitro-Transcribed RNA.Acc Chem Res.54(21),4012–4023(2021)

[0335] 9.Viral RNA recognition by LGP2 and MDA5,and activation of signal ingthrough step-by-step conformational changes.Nucleic Acids Research,11664–11674(2020)

[0336] 10.Structural Basis for dsRNA Recognition,Filament Formation,andAntiviral Signal Activation by MDA5.Cel l 152,276–289(2013)

[0337] 11.A Faci le Method for the Removal of dsRNA Contaminant from InVitro-Transcribed mRNA.Mol Ther Nucleic Acids.15,26-35(2019)

[0338] 12.Synthesis of low immunogenicity RNA with high-temperature in vitrotranscription.RNA.26(3),345-360(2020)

[0339] 13.Double-stranded RNA reduction by chaotropic agents during in vitrotranscription of messenger RNA.Molecular Therapy Nucleic Acids.29,618-624(2022)

[0340] 14.Role of DNA bubble rewinding in enzymatic transcriptiontermination.PNAS,103(13)4870–4875(2006)

[0341] 15.Regulation of Transcription Elongation andTermination.Biomolecules,5(2),1063-1078(2015)

[0342] 16.A novel transcription property of SP6 and T7 RNA polymerases:dependence on template structure.Nucleic Acids Res.13,6223–6236(1995)

[0343] 17.Structure and function of the bacteriophage T7 RNA polymerase (or,the virtues of simplicity).Cell.Mol.Biol.Res.39,385–391(1993a).

[0344] 18.The phage RNA polymerases are related to DNA polymerases andreverse transcriptases.Mol.Microbiol.10,1–6(1993b).

[0345] 19.Evolution of multisubunit RNA polymerases in the three domains oflife.Nature Reviews Microbiology volume 9,pages85–98(2011)

[0346] 20.Structure of Escherichia col i RNA polymerase holoenzyme atlast.PNAS,110(49)19662-19663,(2013)

[0347] 21.Structural basis for substrate loading in bacterial RNApolymerase.Nature 448,163-168(2007)

[0348] 22.Crystal structure of bacterial RNA polymerase bound with atranscription inhibitor protein.Nature 468,978–982(2010)

[0349] 23.Expression and purification of active recombinant T7 RNApolymerase from E.coli.Cold Spring Harb Protoc.11(2013)

[0350] 24.Structural Basis for the transition from initiation to elongationtranscription in T7 RNA polymerase.Science 298,1387-1395(2002)

[0351] 25. Ol igoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res., 15, 8783–8798. (1987)

[0352] 26.A Sensitive,High-Volume,Colorimetric Assay for ProteinPhosphatases.Pharmaceutical Research.11(5),759-763(1994)

[0353] 27.Engineering circular RNA for potent and stable translation ineukaryotic cells.Nature Communications.9:2629(2018)

[0354] 28.Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185,1–17(2022)

[0355] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.

Claims

1. A repression module for suppressing the formation of byproducts in an in vitro transcription reaction, characterized in that: The repression module is located downstream of the double-stranded DNA template in the in vitro transcription reaction system. Wherein, the repression module has the structure shown in Formula Ia: In Formula Ia, the DNA single strand where "5'Z1-Z2-Z3-Z4-Z5 3'" is located is the non-template strand (sense strand); the DNA single strand where "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" is located is the template strand (antisense strand); Furthermore, during in vitro transcription, "5'Z1-Z2-Z3-Z4-Z5 3'" in Formula Ia forms a structure shown in Formula Ib from the 5' end to the 3' end: In Formula Ib, "Z2-Z3-Z4" forms a hairpin structure, wherein Z2 and Z4 are hairpin stems with complementary base pairing, and Z3 is a hairpin loop; Z1 and Z5 are base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1 and Z5 cannot be complementary to each other; And, "3'Z1'-Z2'-Z3'-Z4'-Z5'5'" in Formula Ia forms the structure shown in Formula Ib' from the 3' end to the 5' end: In Formula Ib', "Z2'-Z3'-Z4'" forms a hairpin structure, wherein Z2' and Z4' are the hairpin stems of complementary base pairing, and Z3' is the hairpin loop; Z1' and Z5' are the base sequences at both ends of the hairpin structure, respectively, and the base sequences of Z1' and Z5' cannot be complementary to each other; In Formula Ia, Formula Ib and Formula Ib', "~" each independently represents a hydrogen bond formed by complementary base pairing; "-" each independently represents a chemical bond; and, In the hairpin structure, the length of the hairpin neck, ie, Z2 / Z2' or Z4 / Z4', is 3-10 nt; the length of the hairpin loop, ie, Z3 / Z3', is 3-10 nt.

2. The suppression module according to claim 1, characterized in that The formula Ib structure formed by the repressor module in the non-template strand can suppress the formation of the first byproduct in the in vitro transcription reaction, wherein the first byproduct is antisense RNA and dsRNA, and the dsRNA is dsRNA formed by complementary pairing of antisense RNA and RNA transcription product; The repression module forms a structure of Formula Ib' in the template chain, which can produce an effect similar to internal termination in the IVT reaction, promote the dissociation of the transcription bubble, and thus repress the 3' extension byproducts produced by the continuous abnormal transcription extension of the DNA template chain, also known as transcriptional slippage. The RNA transcribed using the template strand as a template also contains the repressor module, which represses the 3' extension byproduct generated by the self-pairing extension of the RNA. That is, the formation of the second byproduct in the in vitro transcription reaction is suppressed, and the second byproduct is the 3'-end extension byproduct of the RNA transcription product, which includes the transcriptional slippage and the 3' extension byproduct generated by the RNA self-pairing extension.

3. The suppression module according to claim 1, characterized in that The total length of the repression module is 10-42 bp.

4. The suppression module according to claim 1, characterized in that: The total length of the repression module is 20-30 bp.

5. The suppression module according to claim 1, characterized in that The repression module The length of the segments was 9-30 bp.

6. The suppression module according to claim 1, characterized in that: The repression module The length of the segments is 15-20 bp.

7. The suppression module according to claim 1, characterized in that: The total length of Formula Ib or Formula Ib' is 10-42 nt.

8. The suppression module according to claim 1, characterized in that: The total length of Formula Ib or Formula Ib' is 20-30 nt.

9. The suppression module according to claim 1, characterized in that: The length of Z5 / Z5' is at least 1 nt.

10. The suppression module according to claim 1, characterized in that: The length of Z5 / Z5' is 2-6 nt.

11. An artificially constructed double-stranded DNA template for in vitro transcription, characterized in that: The double-stranded DNA template has a repression module downstream for suppressing the formation of byproducts in the in vitro transcription reaction, and the double-stranded DNA template has a structure shown in the following formula IIa or IIb: Wherein, "5'X0-X1-X2-X3 3'" is the non-template strand (sense strand); "3'X0'-X1'-X2'-X3'5'" is the template strand (antisense strand) X0 / X0' is the promoter sequence; X1 / X1' is the target molecule coding sequence in the template; X2 / X2' is none or a connection sequence; X3 / X3' is a repressor module for suppressing the formation of byproducts in an in vitro transcription reaction, which has a structure as shown in Formula Ia as claimed in claim 1; wherein during the in vitro transcription process, X3 forms a structure as shown in Formula Ib as claimed in claim 1, and X3' forms a structure as shown in Formula Ib' as claimed in claim 1; "-" are each independently a chemical bond.

12. The double-stranded DNA template according to claim 11, characterized in that When the double-stranded DNA template has the structure shown in IIb, the 3' end of X0 is connected to 0-5 transcription start bases.

13. An RNA molecule formed by in vitro transcription, characterized in that: The 3' end of the RNA molecule contains a repressor module transcribed from the DNA template chain, which can suppress the formation of 3' extension byproducts generated by RNA self-pairing extension, and the RNA molecule has a structure shown in the following formula III from the 5' end to the 3' end: Y1-Y2-Y3(III) In the formula, Y1 is the coding sequence of the RNA molecule; Y2 is none or a linking sequence; Y3 is a repressor module capable of suppressing the formation of byproducts in an in vitro transcription reaction, which has a structure as shown in Formula Ib as claimed in claim 1; "-" are each independently a chemical bond.

14. The RNA molecule according to claim 13, characterized in that The RNA molecules include mRNA and precursor RNA (pre-mRNA) that forms circRNA.

15. An in vitro transcription reaction system, characterized in that: The reaction system comprises: (1) Pre-reaction system: The pre-reaction system comprises the artificially constructed in vitro transcribed double-stranded DNA template as claimed in claim 11, and (2) Post-reaction system: The post-reaction system contains the RNA molecule formed by in vitro transcription as described in claim 13.

16. The reaction system according to claim 15, characterized in that The pre-reaction system further contains: RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally RNase inhibitor.

17. The reaction system according to claim 16, characterized in that The RNA polymerase includes single-subunit and multi-subunit RNA polymerases.

18. An in vitro transcription reaction kit, characterized in that: The kit comprises: (c1) reaction reagents, comprising the artificially constructed in vitro transcribed double-stranded DNA template as claimed in claim 11, RNA polymerase, NTPs, in vitro transcription reaction buffer, and optionally an RNase inhibitor; and (c2) Instructions.

19. Use of the in vitro transcription reaction system according to claim 15 or the in vitro transcription reaction kit according to claim 18 for producing RNA molecules in vitro.

20. The use according to claim 19, characterized in that The RNA molecules include mRNA and circRNA.

21. An in vitro transcription method, characterized in that: The method comprises the steps of: The in vitro transcription reaction is performed using the in vitro transcription reaction system as described in claim 15 or the in vitro transcription reaction kit as described in claim 18.

22. A method for preparing a target mRNA molecule in vitro, the method comprising the steps of: (i) providing a double-stranded DNA template encoding a target mRNA molecule, wherein the double-stranded DNA template contains the repression module as described in claim 1; (ii) performing an in vitro transcription reaction using the double-stranded DNA template described in step (i) to obtain a crude target mRNA molecule product.

23. A method for preparing a target cricRNA molecule in vitro, the method comprising the steps of: (a) providing a double-stranded DNA template encoding a target circRNA molecule, wherein the double-stranded DNA template contains the repression module as described in claim 1; (b) performing an in vitro transcription reaction using the double-stranded DNA template described in step (a) to obtain a precursor RNA (pre-mRNA) of the target circRNA molecule; (c) The precursor RNA (pre-mRNA) in step (b) undergoes self-cleavage and circularization to form a crude product of the target circRNA molecule.